<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PEN</journal-id>
<journal-id journal-id-type="hwp">sppen</journal-id>
<journal-id journal-id-type="nlm-ta">JPEN J Parenter Enteral Nutr</journal-id>
<journal-title>Journal of Parenteral and Enteral Nutrition</journal-title>
<issn pub-type="ppub">0148-6071</issn>
<issn pub-type="epub">1941-2444</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0148607112456041</article-id>
<article-id pub-id-type="publisher-id">10.1177_0148607112456041</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Nutrition Support and Infections Associated With Hepatic Resection and Liver Transplantation in Patients With Chronic Liver Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Masuda</surname><given-names>Toshiro</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0148607112456041">1</xref>
<xref ref-type="aff" rid="aff2-0148607112456041">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Shirabe</surname><given-names>Ken</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0148607112456041">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yoshiya</surname><given-names>Shohei</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0148607112456041">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Matono</surname><given-names>Rumi</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0148607112456041">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Morita</surname><given-names>Kazutoyo</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0148607112456041">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hashimoto</surname><given-names>Naotaka</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0148607112456041">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ikegami</surname><given-names>Toru</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0148607112456041">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yoshizumi</surname><given-names>Tomoharu</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0148607112456041">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Baba</surname><given-names>Hideo</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff2-0148607112456041">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Maehara</surname><given-names>Yoshihiko</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0148607112456041">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0148607112456041"><label>1</label>Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan</aff>
<aff id="aff2-0148607112456041"><label>2</label>Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan</aff>
<author-notes>
<corresp id="corresp1-0148607112456041">Ken Shirabe, Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka, 812-8582, Japan. Email: <email>kshirabe@surg2.med.kyushu-u.ac.jp</email>.</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2013</year>
</pub-date>
<volume>37</volume>
<issue>3</issue>
<fpage>318</fpage>
<lpage>326</lpage>
<history>
<date date-type="received">
<day>20</day>
<month>2</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>6</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© 2012 American Society for Parenteral and Enteral Nutrition</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">The American Society for Parenteral and Enteral Nutrition</copyright-holder>
</permissions>
<abstract>
<p>Malnutrition is common in liver cirrhotic patients who will undergo liver resection or liver transplantation. A precise evaluation of their nutrition status is thus difficult because of the presence of ascites and the edema caused by their impaired protein synthesis. Both perioperative enteral and parenteral nutrition have benefits in reducing the morbidity and mortality of liver surgery, and in general, oral nutrition supplements are recommended. Branched-chain amino acids (BCAAs) promote protein and glycogen synthesis and regulate immune system function. Synbiotics, a combination of pro- and prebiotics, is reported to enhance immune responses. Oral nutrition support with BCAAs, synbiotics, and an immune-enhancing diet have a beneficial effect on preventing the perioperative infections associated with hepatic resection or liver transplantation.</p>
</abstract>
<kwd-group>
<kwd>nutrition</kwd>
<kwd>infection</kwd>
<kwd>bacteremia</kwd>
<kwd>liver cirrhosis</kwd>
<kwd>liver surgery</kwd>
<kwd>hepatic resection</kwd>
<kwd>liver transplantation</kwd>
<kwd>branched-chain amino acids</kwd>
<kwd>synbiotics</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0148607112456041">
<title>Clinical Relevancy Statement</title>
<p>In liver surgery and transplantation, postoperative infection is one of the most important problems that cause postoperative morbidity and mortality. The nutrition therapy may improve the clinical outcome in cirrhotic patients undergoing hepatic surgery and liver transplantation. This review focused on the role of nutrition supports especially on perioperative infection or sepsis.</p>
</sec>
<sec id="section2-0148607112456041" sec-type="intro">
<title>Introduction</title>
<p>Malnutrition is a common complication of chronic liver diseases, and it is an independent risk factor for survival in patients with liver cirrhosis.<sup><xref ref-type="bibr" rid="bibr1-0148607112456041">1</xref><xref ref-type="bibr" rid="bibr2-0148607112456041"/>-<xref ref-type="bibr" rid="bibr3-0148607112456041">3</xref></sup> Inadequate dietary protein intake may have a deleterious effect on hepatic encephalopathy, nutrition status, and clinical outcome in patients with end-stage liver failure.<sup><xref ref-type="bibr" rid="bibr4-0148607112456041">4</xref>,<xref ref-type="bibr" rid="bibr5-0148607112456041">5</xref></sup> In patients with an indication for liver surgery and/or transplantation, a decreased liver function with nutrition deficiency is common. This poor nutrition status before hepatic resection or transplantation has been suggested to increase the risk of postoperative complications and/or mortality.<sup><xref ref-type="bibr" rid="bibr6-0148607112456041">6</xref><xref ref-type="bibr" rid="bibr7-0148607112456041"/><xref ref-type="bibr" rid="bibr8-0148607112456041"/><xref ref-type="bibr" rid="bibr9-0148607112456041"/><xref ref-type="bibr" rid="bibr10-0148607112456041"/><xref ref-type="bibr" rid="bibr11-0148607112456041"/>-<xref ref-type="bibr" rid="bibr12-0148607112456041">12</xref></sup> However, other reports suggest that the nutrition parameters and markers of disease severity do not correlate with the outcomes after liver transplantation.<sup><xref ref-type="bibr" rid="bibr13-0148607112456041">13</xref></sup></p>
<p>The branched-chain amino acids (BCAAs)—leucine, isoleucine, and valine—are essential amino acids, especially in patients with liver cirrhosis, and may have an effect on hepatic encephalopathy, immunity, and infections.<sup><xref ref-type="bibr" rid="bibr14-0148607112456041">14</xref><xref ref-type="bibr" rid="bibr15-0148607112456041"/><xref ref-type="bibr" rid="bibr16-0148607112456041"/>-<xref ref-type="bibr" rid="bibr17-0148607112456041">17</xref></sup></p>
<p>Postoperative infections are one of the most important problems leading to postoperative morbidity and mortality in patients who undergo liver surgery or transplantation.<sup><xref ref-type="bibr" rid="bibr18-0148607112456041">18</xref></sup> The recipients’ preoperative malnutrition is a risk factor that increases infectious complications after liver transplantation.<sup><xref ref-type="bibr" rid="bibr12-0148607112456041">12</xref>,<xref ref-type="bibr" rid="bibr19-0148607112456041">19</xref><xref ref-type="bibr" rid="bibr20-0148607112456041"/>-<xref ref-type="bibr" rid="bibr21-0148607112456041">21</xref></sup> In fact, several reports have shown that a decreased liver function before liver transplantation may be related to postoperative bacteremia.<sup><xref ref-type="bibr" rid="bibr22-0148607112456041">22</xref><xref ref-type="bibr" rid="bibr23-0148607112456041"/><xref ref-type="bibr" rid="bibr24-0148607112456041"/>-<xref ref-type="bibr" rid="bibr25-0148607112456041">25</xref></sup> The use of nutrition therapy may improve the clinical outcome in cirrhotic patients undergoing general surgery and liver transplantation.<sup><xref ref-type="bibr" rid="bibr8-0148607112456041">8</xref></sup></p>
<p>This review focuses on the role of nutrition support, especially on the development of perioperative infection or sepsis after hepatic resection and liver transplantation. The reports mainly published after 1995 were assembled and discussed.</p>
<sec id="section3-0148607112456041">
<title>Prevalence of Malnutrition in Cirrhotic Patients</title>
<p>Malnutrition develops in patients with cirrhosis independent of the etiology.<sup><xref ref-type="bibr" rid="bibr6-0148607112456041">6</xref>,<xref ref-type="bibr" rid="bibr26-0148607112456041">26</xref></sup> The prevalence of malnutrition is reported to be 50%–90% in cirrhotic patients.<sup><xref ref-type="bibr" rid="bibr27-0148607112456041">27</xref></sup> A multicenter Italian study including more than 1400 patients with cirrhosis showed malnutrition to be recognized in 20% of patients with Child-Pugh class A and in 50%–60% of patients with Child-Pugh class C.<sup><xref ref-type="bibr" rid="bibr8-0148607112456041">8</xref>,<xref ref-type="bibr" rid="bibr28-0148607112456041">28</xref></sup> Actually, the prevalence of malnutrition in cirrhotic patients may depend on how the nutrition assessment was performed.<sup><xref ref-type="bibr" rid="bibr8-0148607112456041">8</xref></sup></p>
</sec>
<sec id="section4-0148607112456041">
<title>Mechanisms Responsible for the High Frequency of Infections in Cirrhosis</title>
<p>Cirrhotic liver patients show a high frequency of infections such as spontaneous bacterial peritonitis (SBP), bacteremia/sepsis, respiratory tract infections, urinary tract infections, meningitis, endocarditis, phlegmonous colitis, and hepatic abscess.<sup><xref ref-type="bibr" rid="bibr29-0148607112456041">29</xref></sup> Bacterial translocation is reported to be a key mechanism of SBP.<sup><xref ref-type="bibr" rid="bibr30-0148607112456041">30</xref></sup> The pathogenetic mechanisms of such a high susceptibility of infections may be associated with polymorphonuclear leucocyte dysfunction, complement deficiency, reticuloendothelial system dysfunction, macrophage dysfunction, increased production of interleukins, and decreased tumor necrosis factor (TNF)–α activity.<sup><xref ref-type="bibr" rid="bibr29-0148607112456041">29</xref></sup></p>
</sec>
</sec>
<sec id="section5-0148607112456041">
<title>Assessment of Nutrition Status</title>
<p>Assessing the nutrition status of patients with liver dysfunction is often difficult because of the fluid collections caused by the impaired protein synthesis in these patients. Weight is not a reliable indicator of malnutrition because of the presence of ascites and edema, which may lead to an increase in body weight despite a reduction in lean body mass.<sup><xref ref-type="bibr" rid="bibr6-0148607112456041">6</xref></sup> Body mass index (BMI) may afford a more reliable indicator of malnutrition if different cutoff values are used depending on the presence and severity of ascites.<sup><xref ref-type="bibr" rid="bibr31-0148607112456041">31</xref></sup></p>
<p>Anthropometry measurements include the triceps skin-fold thickness, mid-arm circumference (MAC), and mid-arm muscle circumference (MAMC), assessing the skeletal muscle mass.<sup><xref ref-type="bibr" rid="bibr32-0148607112456041">32</xref><xref ref-type="bibr" rid="bibr33-0148607112456041"/>-<xref ref-type="bibr" rid="bibr34-0148607112456041">34</xref></sup> Subjective global assessment (SGA) is a technique that combines multiple elements of nutrition assessment to classify the severity of malnutrition (Supplement 1).<sup><xref ref-type="bibr" rid="bibr32-0148607112456041">32</xref>,<xref ref-type="bibr" rid="bibr35-0148607112456041">35</xref><xref ref-type="bibr" rid="bibr36-0148607112456041"/>-<xref ref-type="bibr" rid="bibr37-0148607112456041">37</xref></sup> These components include weight loss during the previous 6 months, changes in dietary intake, gastrointestinal symptoms, functional capacity, metabolic demands, signs of muscle wasting, and the presence of edema in the lower extremities.<sup><xref ref-type="bibr" rid="bibr35-0148607112456041">35</xref></sup> The SGA is not affected by fluid retention or the formation of ascites.<sup><xref ref-type="bibr" rid="bibr38-0148607112456041">38</xref></sup> A modified SGA, named the Royal Free Hospital–SGA, combines a subjective assessment of the nutrition status with BMI, MAMC, and dietary intake.<sup><xref ref-type="bibr" rid="bibr38-0148607112456041">38</xref>,<xref ref-type="bibr" rid="bibr39-0148607112456041">39</xref></sup> Assessment of muscle function, determined by measuring hand-grip strength and respiratory muscle strength, has also been used in nutrition evaluation.<sup><xref ref-type="bibr" rid="bibr12-0148607112456041">12</xref>,<xref ref-type="bibr" rid="bibr31-0148607112456041">31</xref>,<xref ref-type="bibr" rid="bibr40-0148607112456041">40</xref></sup> Recently, sarcopenia in the lumbar skeletal muscle, as calculated by computed tomography, has been used to evaluate the nutrition state or degree of liver dysfunction.<sup><xref ref-type="bibr" rid="bibr41-0148607112456041">41</xref></sup> In patients undergoing liver transplantation, it is reported that sarcopenia correlates with post–liver transplant mortality.<sup><xref ref-type="bibr" rid="bibr42-0148607112456041">42</xref></sup> Concerning muscular status, the level of 3-methylhistidine is a marker of muscular proteolysis and can be used as a nutrition marker.<sup><xref ref-type="bibr" rid="bibr43-0148607112456041">43</xref></sup></p>
<p>Depletion of the body cell mass (BCM) is a useful estimation of nutrition status.<sup><xref ref-type="bibr" rid="bibr11-0148607112456041">11</xref>,<xref ref-type="bibr" rid="bibr44-0148607112456041">44</xref></sup> Bioelectrical impedance is a more readily available tool for estimating the BCM.<sup><xref ref-type="bibr" rid="bibr45-0148607112456041">45</xref></sup> An evaluation of the status of energy metabolism might be a reasonable component of a nutrition assessment because there seems to be a correlation between hypermetabolism and malnutrition.<sup><xref ref-type="bibr" rid="bibr6-0148607112456041">6</xref></sup></p>
<p>The concentrations of rapid turnover proteins, such as serum albumin, prealbumin, retinal-binding protein (RBP),<sup><xref ref-type="bibr" rid="bibr46-0148607112456041">46</xref></sup> and transferrin,<sup><xref ref-type="bibr" rid="bibr47-0148607112456041">47</xref></sup> may be low because of low levels of synthesis, rather than because of poor nutrition status.<sup><xref ref-type="bibr" rid="bibr6-0148607112456041">6</xref></sup> Some reports have suggested that alterations in serum albumin level improve both surgical and postsurgical complications of liver transplantation.<sup><xref ref-type="bibr" rid="bibr48-0148607112456041">48</xref><xref ref-type="bibr" rid="bibr49-0148607112456041"/>-<xref ref-type="bibr" rid="bibr50-0148607112456041">50</xref></sup> These proteins, especially serum albumin, correlate with liver function and may not be reliable as a nutrition marker in cirrhotic patients.<sup><xref ref-type="bibr" rid="bibr51-0148607112456041">51</xref></sup> In patients with relatively stable liver disease, rapid turnover proteins may be simple and useful nutrition markers.</p>
<p>Various other measures can indicate the nutrition status. For example, an imbalance in the plasma levels of aromatic amino acids (AAAs) and BCAA, the so-called Fisher’s ratio, or the BCAA/tyrosine ratio (BTR) has been demonstrated to have a causal role in hepatic encephalopathy.<sup><xref ref-type="bibr" rid="bibr52-0148607112456041">52</xref></sup></p>
<p>The nonprotein respiratory quotient (npRQ), a unitless number estimated from carbon dioxide production, is used to evaluate the nutrition status of patients with liver cirrhosis.<sup><xref ref-type="bibr" rid="bibr53-0148607112456041">53</xref></sup></p>
<p>The homeostasis model assessment (HOMA), a method used to quantify insulin resistance and β-cell function,<sup><xref ref-type="bibr" rid="bibr54-0148607112456041">54</xref>,<xref ref-type="bibr" rid="bibr55-0148607112456041">55</xref></sup> has been reported to accurately reflect nutrition status in patients with nonalcoholic fatty liver disease.<sup><xref ref-type="bibr" rid="bibr55-0148607112456041">55</xref></sup></p>
<p>Combinations of some anthropometric measurements, physical examinations, and laboratory data can be more reliable to assess nutrition status in patients with relatively stable liver disease who are scheduled to undergo a liver resection. A marker that is not related to the fluid collection, such as sarcopenia, might reliably determine nutrition status in patients with severe liver dysfunction expecting liver transplantation.</p>
</sec>
<sec id="section6-0148607112456041">
<title>Parenteral Nutrition</title>
<p>In vitro, liver regeneration can be accelerated by administering a parenteral nutrition (PN) solution tailored to normalize the plasma amino acids associated with compromised liver function.<sup><xref ref-type="bibr" rid="bibr56-0148607112456041">56</xref></sup> Fan et al<sup><xref ref-type="bibr" rid="bibr57-0148607112456041">57</xref></sup> reported that perioperative intravenous (IV) nutrition support, in addition to oral diet, can reduce the complications after major hepatectomy in cirrhotic patients. PN is indicated for malnourished cirrhotic patients who cannot be nourished sufficiently by either the oral or enteral routes.<sup><xref ref-type="bibr" rid="bibr58-0148607112456041">58</xref></sup> It has been reported that enteral nutrition (EN) and PN were equally effective for maintaining nutrition status after liver transplantation and decreasing complications and cost.<sup><xref ref-type="bibr" rid="bibr59-0148607112456041">59</xref></sup> Plauth et al<sup><xref ref-type="bibr" rid="bibr60-0148607112456041">60</xref></sup> suggested that parenteral feeding might be superior to enteral feeding in patients with portosystemic shunting because enteral feeding might worsen hyperammonemia.</p>
</sec>
<sec id="section7-0148607112456041">
<title>Enteral Nutrition</title>
<p>The European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines (see <xref ref-type="table" rid="table1-0148607112456041">Table 1</xref>) advocate that patients with liver cirrhosis should receive 35–40 kcal/kg/d with 1.2–1.5 g/kg protein/d.<sup><xref ref-type="bibr" rid="bibr32-0148607112456041">32</xref></sup> In general, oral nutrition supplements are recommended for patients without any contraindications such as ileus.<sup><xref ref-type="bibr" rid="bibr32-0148607112456041">32</xref></sup> If patients cannot maintain adequate oral intake, tube feeding is recommended even when esophageal varices are present.<sup><xref ref-type="bibr" rid="bibr32-0148607112456041">32</xref></sup> It was recently reported that protein restriction in patients with liver failure has no impact on the encephalopathy and even worsens nutrition status.<sup><xref ref-type="bibr" rid="bibr61-0148607112456041">61</xref></sup> Cordoba et al<sup><xref ref-type="bibr" rid="bibr4-0148607112456041">4</xref></sup> reported that diets with a normal protein content can be safely administered to cirrhotic patients with episodic hepatic encephalopathy. Many reports have described the effects of oral nutrition supplementation in patients with alcoholic cirrhosis.<sup><xref ref-type="bibr" rid="bibr62-0148607112456041">62</xref><xref ref-type="bibr" rid="bibr63-0148607112456041"/><xref ref-type="bibr" rid="bibr64-0148607112456041"/><xref ref-type="bibr" rid="bibr65-0148607112456041"/>-<xref ref-type="bibr" rid="bibr66-0148607112456041">66</xref></sup> For example, Le Cornu et al<sup><xref ref-type="bibr" rid="bibr67-0148607112456041">67</xref></sup> reported that regular dietary counseling is as effective for increasing energy intake as providing a nutrition supplement. Other reports also have exhibited the superiority of the safety and efficacy in terms of postoperative complication rates for postoperative early EN compared with PN.<sup><xref ref-type="bibr" rid="bibr68-0148607112456041">68</xref><xref ref-type="bibr" rid="bibr69-0148607112456041"/>-<xref ref-type="bibr" rid="bibr70-0148607112456041">70</xref></sup> The American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) guidelines (see <xref ref-type="table" rid="table1-0148607112456041">Table 1</xref>) also support the concept that EN is favored to preserve gut integrity and immune markers and to simplify glycemic management.<sup><xref ref-type="bibr" rid="bibr71-0148607112456041">71</xref></sup> In adult living donor liver transplantation, Kaido et al<sup><xref ref-type="bibr" rid="bibr72-0148607112456041">72</xref></sup> reported that EN is a promising strategy to improve postoperative mortality and morbidity rates.</p>
<table-wrap id="table1-0148607112456041" position="float">
<label>Table 1.</label>
<caption>
<p>ESPEN and A.S.P.E.N. Guidelines for Cirrhotic Patients.</p>
</caption>
<graphic alternate-form-of="table1-0148607112456041" xlink:href="10.1177_0148607112456041-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<tbody>
<tr>
<td>ESPEN guidelines<xref ref-type="bibr" rid="bibr32-0148607112456041">32</xref></td>
<td>35–40 kcal/kg/d</td>
</tr>
<tr>
<td/>
<td>Enteral nutrition is recommended.</td>
</tr>
<tr>
<td/>
<td>Supplemental nutrition, especially BCAA-enriched formula, is preferred.</td>
</tr>
<tr>
<td>A.S.P.E.N. guidelines<xref ref-type="bibr" rid="bibr119-0148607112456041">119</xref></td>
<td/>
</tr>
<tr>
<td> Without encephalopathy</td>
<td>25–35 kcal/kg/d</td>
</tr>
<tr>
<td> With acute encephalopathy</td>
<td>35 kcal/kg/d</td>
</tr>
<tr>
<td> Stable and malnourished</td>
<td>30–40 kcal/kg/d</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0148607112456041">
<p>A.S.P.E.N., American Society for Parenteral and Enteral Nutrition; BCAA, branched-chain amino acid; ESPEN, European Society for Clinical Nutrition and Metabolism.</p></fn>
</table-wrap-foot></table-wrap>
</sec>
<sec id="section8-0148607112456041">
<title>Branched-Chain Amino Acids</title>
<p>Oral supplementation with essential amino acids can improve hepatic encephalopathy and the quality of life in not only cirrhotic patients but also institutionalized elderly patients.<sup><xref ref-type="bibr" rid="bibr73-0148607112456041">73</xref><xref ref-type="bibr" rid="bibr74-0148607112456041"/>-<xref ref-type="bibr" rid="bibr75-0148607112456041">75</xref></sup> Supplemental BCAA is commonly applied in patients with liver cirrhosis,<sup><xref ref-type="bibr" rid="bibr76-0148607112456041">76</xref>,<xref ref-type="bibr" rid="bibr77-0148607112456041">77</xref></sup> especially compensated cirrhosis<sup><xref ref-type="bibr" rid="bibr78-0148607112456041">78</xref>,<xref ref-type="bibr" rid="bibr79-0148607112456041">79</xref></sup> or hepatocellular carcinoma.<sup><xref ref-type="bibr" rid="bibr80-0148607112456041">80</xref><xref ref-type="bibr" rid="bibr81-0148607112456041"/><xref ref-type="bibr" rid="bibr82-0148607112456041"/><xref ref-type="bibr" rid="bibr83-0148607112456041"/><xref ref-type="bibr" rid="bibr84-0148607112456041"/>-<xref ref-type="bibr" rid="bibr85-0148607112456041">85</xref></sup> The ESPEN guidelines recommend the use of BCAA-enriched supplements in patients with hepatic encephalopathy.<sup><xref ref-type="bibr" rid="bibr32-0148607112456041">32</xref></sup> It was proposed that depletion of BCAAs, as seen in many patients with advanced liver disease, promotes the development of hepatic encephalopathy by enhancing the passage of AAAs across the blood-brain barrier, resulting in the synthesis of false neurotransmitters.<sup><xref ref-type="bibr" rid="bibr6-0148607112456041">6</xref></sup> In addition, the administration of solutions enriched with BCAAs has been shown to improve cerebral perfusion in cirrhotic patients.<sup><xref ref-type="bibr" rid="bibr86-0148607112456041">86</xref></sup></p>
<p>In prospective studies, it was reported that long-term oral supplementation with a BCAA mixture improved the serum albumin level, as well as the cellular energy metabolism and quality of life in cirrhotic patients.<sup><xref ref-type="bibr" rid="bibr77-0148607112456041">77</xref>,<xref ref-type="bibr" rid="bibr87-0148607112456041">87</xref></sup> The timing of the supplementation with BCAA is also important. It was reported that nocturnal BCAA administration as a late evening snack (LES) improved the serum albumin level in cirrhotic patients who showed no improvement in their serum albumin levels with daytime BCAA administration.<sup><xref ref-type="bibr" rid="bibr53-0148607112456041">53</xref>,<xref ref-type="bibr" rid="bibr88-0148607112456041">88</xref>,<xref ref-type="bibr" rid="bibr89-0148607112456041">89</xref></sup> Recently, many reports have shown that BCAA supplementation can improve not only energy metabolism and BTR but also glucose tolerance.<sup><xref ref-type="bibr" rid="bibr90-0148607112456041">90</xref><xref ref-type="bibr" rid="bibr91-0148607112456041"/><xref ref-type="bibr" rid="bibr92-0148607112456041"/><xref ref-type="bibr" rid="bibr93-0148607112456041"/><xref ref-type="bibr" rid="bibr94-0148607112456041"/>-<xref ref-type="bibr" rid="bibr95-0148607112456041">95</xref></sup></p>
<p>There have been reports that perioperative administration of BCAA to patients undergoing hepatic resection quickly improves liver function during the early postoperative period.<sup><xref ref-type="bibr" rid="bibr81-0148607112456041">81</xref>,<xref ref-type="bibr" rid="bibr96-0148607112456041">96</xref>,<xref ref-type="bibr" rid="bibr97-0148607112456041">97</xref></sup> Ishikawa et al<sup><xref ref-type="bibr" rid="bibr98-0148607112456041">98</xref></sup> reported that short-term oral nutrition support with BCAA was associated with higher serum erythropoietin levels in patients with nonhepatitis liver disease who underwent curative hepatic resection. They suggested that it had benefits in protecting liver cells from ischemic injury and preventing intraoperative hemorrhage.<sup><xref ref-type="bibr" rid="bibr98-0148607112456041">98</xref></sup></p>
<p>In liver transplantation patients, perioperative supplementation with BCAA-enriched nutrients can improve the nutrition and metabolic disorders associated with end-stage liver disease.<sup><xref ref-type="bibr" rid="bibr99-0148607112456041">99</xref></sup> Early interventional oral BCAAs might prolong the liver transplant waiting period by preserving the hepatic reserve in patients with cirrhosis.<sup><xref ref-type="bibr" rid="bibr100-0148607112456041">100</xref></sup> Recently, the effectiveness of amino acid (ie, glycine, taurine, N-acetylcysteine, arginine, and methionine) supplementation in protecting against ischemia/reperfusion injury (IRI) has attracted attention.<sup><xref ref-type="bibr" rid="bibr101-0148607112456041">101</xref></sup></p>
<p><xref ref-type="fig" rid="fig1-0148607112456041">Figure 1</xref> shows a schematic representation of the activities of BCAA. BCAA, especially leucine, activates the mTOR signaling pathways and inhibits protein degradation in vitro, thus resulting in the promotion of protein synthesis.<sup><xref ref-type="bibr" rid="bibr102-0148607112456041">102</xref>,<xref ref-type="bibr" rid="bibr103-0148607112456041">103</xref></sup> Furthermore, in a cirrhotic rat model, leucine activated glycogen synthase via mTOR signaling and improved glucose metabolism.<sup><xref ref-type="bibr" rid="bibr104-0148607112456041">104</xref></sup> Several reports have suggested that BCAA supplementation can restore or regulate the immune function in patients with advanced cirrhosis.<sup><xref ref-type="bibr" rid="bibr105-0148607112456041">105</xref><xref ref-type="bibr" rid="bibr106-0148607112456041"/><xref ref-type="bibr" rid="bibr107-0148607112456041"/><xref ref-type="bibr" rid="bibr108-0148607112456041"/>-<xref ref-type="bibr" rid="bibr109-0148607112456041">109</xref></sup> Calder<sup><xref ref-type="bibr" rid="bibr14-0148607112456041">14</xref></sup> reported that the essentiality of BCAA for the function of immune cells relates to protein synthesis. Kakazu et al<sup><xref ref-type="bibr" rid="bibr107-0148607112456041">107</xref>,<xref ref-type="bibr" rid="bibr108-0148607112456041">108</xref></sup> reported that an elevation of the BCAA level improved the function of myeloid dendritic cells and that this was beneficial to immune function. Nakamura et al<sup><xref ref-type="bibr" rid="bibr105-0148607112456041">105</xref>,<xref ref-type="bibr" rid="bibr106-0148607112456041">106</xref></sup> reported that the phagocytic functions of neutrophils and the natural killer activity of lymphocytes obtained from patients with liver cirrhosis were restored by oral supplementation with BCAAs.</p>
<fig id="fig1-0148607112456041" position="float">
<label>Figure 1.</label>
<caption>
<p>A schematic representation of the activities of branched-chain amino acids (BCAAs). BCAAs promote protein synthesis by activating mTOR signaling in the liver. In the skeletal muscle, BCAAs promote glycogen synthesis via the activation of mTOR signaling. In addition, BCAAs regulate immune system function by activating the myeloid dendritic cell function and improving the phagocytic function of neutrophils.</p>
</caption>
<graphic xlink:href="10.1177_0148607112456041-fig1.tif"/></fig>
</sec>
<sec id="section9-0148607112456041">
<title>Synbiotics</title>
<p>Selective bowel decontamination increases the incidence of cholangitis and bacterial infections.<sup><xref ref-type="bibr" rid="bibr110-0148607112456041">110</xref></sup> Synbiotics, a combination of pro- and prebiotics, increase the intestinal content of lactic acid–type bacteria in hepatic encephalopathy patients with end-stage liver failure.<sup><xref ref-type="bibr" rid="bibr48-0148607112456041">48</xref></sup> Sugawara et al<sup><xref ref-type="bibr" rid="bibr111-0148607112456041">111</xref></sup> reported that preoperative oral administration of synbiotics can enhance immune responses, attenuate systemic postoperative inflammatory responses, and improve the intestinal microbial environment.</p>
</sec>
<sec id="section10-0148607112456041">
<title>Beneficial Effects of Nutrition Support Against Infections Associated With Liver Surgery (<xref ref-type="table" rid="table2-0148607112456041">Table 2</xref>)</title>
<p>Fan et al<sup><xref ref-type="bibr" rid="bibr57-0148607112456041">57</xref></sup> evaluated the effects of perioperative PN in addition to a typical oral diet, from 7 days before hepatic resection and continued for 7 days after the operation. Perioperative PN in addition to a normal oral diet was associated with a significant reduction in infectious complications (a normal oral diet plus PN: 17% vs control: 37%).<sup><xref ref-type="bibr" rid="bibr57-0148607112456041">57</xref></sup> This relatively large prospective study has sufficient power to show the benefits of nutrition support for preventing the occurrence of infection after liver surgery. Shirabe et al<sup><xref ref-type="bibr" rid="bibr69-0148607112456041">69</xref></sup> prospectively compared postoperative early EN and PN. Early enteral feeding had a tendency to reduce the infection rate after major hepatic resection (early EN: 8% vs PN: 31%), without statistical significance due to the small number of patients. Mochizuki et al<sup><xref ref-type="bibr" rid="bibr70-0148607112456041">70</xref></sup> retrospectively and prospectively compared postoperative EN and PN. Although it was a retrospective study with nonrandomized prospective data, the infection rate of patients in the early EN group, especially high-risk patients, was markedly decreased.<sup><xref ref-type="bibr" rid="bibr70-0148607112456041">70</xref></sup> Okabayashi et al<sup><xref ref-type="bibr" rid="bibr112-0148607112456041">112</xref></sup> evaluated the benefits of perioperative supplementation of BCAA-enriched nutrients in patients undergoing hepatic resection. Postoperative surgical site infection tended to be lower in the BCAA supplementation group (5%) than in the control group (15.3%). However, this retrospective study only briefly discussed “infectious” complications, and therefore the impact of BCAA supplementation on preventing postoperative infections still remains insufficiently described, and thus further studies are expected.</p>
<table-wrap id="table2-0148607112456041" position="float">
<label>Table 2.</label>
<caption>
<p>Beneficial Effects of Perioperative Nutrition Support in Reducing Infections in Patients Undergoing Hepatic Resection.</p>
</caption>
<graphic alternate-form-of="table2-0148607112456041" xlink:href="10.1177_0148607112456041-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Authors</th>
<th align="center">Study Design</th>
<th align="center">Patient No.</th>
<th align="center">Nutrition Therapy (Infection Rates)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Fan et al,<sup><xref ref-type="bibr" rid="bibr57-0148607112456041">57</xref></sup> 1994</td>
<td>Prospective study</td>
<td>124 (64 with PN and 60 with oral diet alone)</td>
<td>Pre- and postoperative PN in addition to oral diet (17%) and oral diet alone (37%)</td>
</tr>
<tr>
<td>Shirabe et al,<sup><xref ref-type="bibr" rid="bibr69-0148607112456041">69</xref></sup> 1997</td>
<td>Prospective study</td>
<td>26 (13 with early EN and 13 with PN)</td>
<td>Postoperative early EN (8%) and PN (31%)</td>
</tr>
<tr>
<td>Mochizuki et al,<sup><xref ref-type="bibr" rid="bibr70-0148607112456041">70</xref></sup> 2000</td>
<td>Retrospective and prospective study</td>
<td>67 (19 with early EN and 48 with PN)</td>
<td>Postoperative early EN (30%) and PN (73.1%)</td>
</tr>
<tr>
<td>Okabayashi et al,<sup><xref ref-type="bibr" rid="bibr112-0148607112456041">112</xref></sup> 2008</td>
<td>Retrospective study</td>
<td>112 (40 with BCAA supplementation and 72 with control)</td>
<td>Pre- and postoperative BCAA-enriched nutrition (5%) and control (15.3%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0148607112456041"><p>BCAA, branched-chain amino acid; EN, enteral nutrition; PN, parenteral nutrition.</p></fn>
</table-wrap-foot></table-wrap>
<p>In hepatic resection for patients with liver disease, perioperative nutrition support, either enteral or parenteral, can reduce septic complications. Furthermore, postoperative early EN, especially BCAA-enriched nutrition, may prevent postoperative infections.</p>
</sec>
<sec id="section11-0148607112456041">
<title>Beneficial Effects of Nutrition Support Against Infections Associated With Transplantation (<xref ref-type="table" rid="table3-0148607112456041">Table 3</xref>)</title>
<p>Hasse et al<sup><xref ref-type="bibr" rid="bibr113-0148607112456041">113</xref></sup> evaluated the benefits of receiving EN via nasointestinal feeding tubes before initiating an oral diet. Nutrition support therapy decreased the incidence of viral infection (enteral tube feeding: 0% vs control: 17.7%) and showed a trend to decrease bacterial (enteral tube feeding: 14.3% vs control: 29.4%) and overall (enteral tube feeding: 21.4% vs control: 47.1%) infections.<sup><xref ref-type="bibr" rid="bibr113-0148607112456041">113</xref></sup> Although this was a small-group study, this proves the benefits of early EN in preventing both viral and bacterial infections. Shirabe et al<sup><xref ref-type="bibr" rid="bibr22-0148607112456041">22</xref></sup> evaluated the effectiveness of preoperative oral supplementation with BCAA. Preoperative BCAA supplementation reduced the incidence of bacteremia (BCAA supplementation: 6.7% vs control: 22.0%) after living donor liver transplantation. Although it is a retrospective study, it was valuable because it included a large number of patients and the infectious complication rates were quite low in the preoperative BCAA supplementation group. Some <italic>Lactobacillus</italic> species have been shown to initiate immunoglobulin production, restore macrophage function, stimulate apoptosis, and modulate lymphocyte function.<sup><xref ref-type="bibr" rid="bibr114-0148607112456041">114</xref></sup> In addition, <italic>Lactobacillus</italic> is reported to influence cytokine release, increase mucin production, eliminate toxins, and stimulate mucosal growth.<sup><xref ref-type="bibr" rid="bibr114-0148607112456041">114</xref></sup> Rayes et al<sup><xref ref-type="bibr" rid="bibr114-0148607112456041">114</xref>,<xref ref-type="bibr" rid="bibr115-0148607112456041">115</xref></sup> reported the benefits of a perioperative supply of synbiotics. The patients who received living <italic>Lactobacillus plantarum 299</italic> plus fiber developed fewer bacterial infections (13%) than did control patients (48%).<sup><xref ref-type="bibr" rid="bibr114-0148607112456041">114</xref></sup> In addition, the incidence of postoperative bacterial infections was lower (3%) with lactic acid bacteria and fiber than in the 48% of patients who consumed only fiber.<sup><xref ref-type="bibr" rid="bibr115-0148607112456041">115</xref></sup> Supplementation with ω-3 fatty acids downregulated proinflammatory cytokine production and modulated eicosanoid synthesis.<sup><xref ref-type="bibr" rid="bibr116-0148607112456041">116</xref></sup> In addition, arginine stimulated the release of growth hormone and insulin, improved nitrogen balance and wound healing, upregulated immune function, and enhanced nitric oxide (NO) biosynthesis.<sup><xref ref-type="bibr" rid="bibr116-0148607112456041">116</xref></sup> Plank et al<sup><xref ref-type="bibr" rid="bibr117-0148607112456041">117</xref></sup> evaluated the effects of a pre- and postoperative enteral immune-enhancing diet. Infectious complications were less common in patients who received immunonutrition (33% in the immunonutrition group and 71% in the control group), although there were no significant differences.<sup><xref ref-type="bibr" rid="bibr117-0148607112456041">117</xref></sup> Similarly, Kaido et al<sup><xref ref-type="bibr" rid="bibr118-0148607112456041">118</xref></sup> reported the benefit of postoperative early EN with an immunomodulatory diet. The incidence of posttransplant bacteremia was lower in the immunomodulatory diet group (10%) than in the conventional enteral diet group (50%).<sup><xref ref-type="bibr" rid="bibr118-0148607112456041">118</xref></sup> This prospective study showed a much lower rate of infectious complications in the immune-enhancing diet group. A randomized controlled study evaluating the effect of preoperative long-term immunonutrition in patients listed for liver transplantation is planned in Europe.<sup><xref ref-type="bibr" rid="bibr116-0148607112456041">116</xref></sup></p>
<table-wrap id="table3-0148607112456041" position="float">
<label>Table 3.</label>
<caption>
<p>Beneficial Effects of Perioperative Nutrition Support in Reducing Infections in Patients Undergoing Liver Transplantation.</p>
</caption>
<graphic alternate-form-of="table3-0148607112456041" xlink:href="10.1177_0148607112456041-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Authors</th>
<th align="center">Study Design</th>
<th align="center">Patient No.</th>
<th align="center">Nutrition Therapy (Infection Rates)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hasse et al,<sup><xref ref-type="bibr" rid="bibr113-0148607112456041">113</xref></sup> 1995</td>
<td>Prospective study</td>
<td>31 (14 with tube feeding and 17 with control)</td>
<td>Postoperative tube feeding (21.4%) and control (47.1%)</td>
</tr>
<tr>
<td>Rayes et al,<sup><xref ref-type="bibr" rid="bibr114-0148607112456041">114</xref></sup> 2002</td>
<td>Prospective study</td>
<td>95 (32 with selective bowel decontamination, 31 with <italic>Lactobacillus</italic>, and 32 with placebo )</td>
<td>Postoperative early EN with <italic>Lactobacillus</italic> (13%) and control (48%)</td>
</tr>
<tr>
<td>Rayes et al,<sup><xref ref-type="bibr" rid="bibr115-0148607112456041">115</xref></sup> 2005</td>
<td>Prospective study</td>
<td>66 (33 with lactic acid bacteria and fiber and 33 with fiber only)</td>
<td>Postoperative early EN with lactic acid bacteria and fiber (3%) and only fiber (48%)</td>
</tr>
<tr>
<td>Plank et al,<sup><xref ref-type="bibr" rid="bibr117-0148607112456041">117</xref></sup> 2005</td>
<td>Retrospective study</td>
<td>32 (15 with perioperative immunonutrition and 17 with control)</td>
<td>Pre- and postoperative immune-enhancing diet (33%) and control (71%)</td>
</tr>
<tr>
<td>Kaido et al,<sup><xref ref-type="bibr" rid="bibr118-0148607112456041">118</xref></sup> 2010</td>
<td>Prospective study</td>
<td>30 (10 with postoperative early immunomodulating nutrition and 20 with conventional enteral diet)</td>
<td>Postoperative early EN with immunomodulating diet (10%) and control (50%)</td>
</tr>
<tr>
<td>Shirabe et al,<sup><xref ref-type="bibr" rid="bibr22-0148607112456041">22</xref></sup> 2011</td>
<td>Retrospective study</td>
<td>236 (129 with BCAA supplementation and 107 with control)</td>
<td>Preoperative BCAA supplementation (6.7%) and control (22.0%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0148607112456041"><p>BCAA, branched-chain amino acid; EN, enteral nutrition.</p></fn>
</table-wrap-foot></table-wrap>
<p>In summary, in patients undergoing liver transplantation, early posttransplant tube feeding is recommended. As early postoperative nutrition, solutions containing pre- and probiotics have some effects to prevent postoperative infections. Preoperative supplementation with BCAA may improve patient malnutrition and reduce the risk of postoperative infections. A pre- and postoperative immune system–enhancing diet increasingly has been demonstrated to have benefits in preventing posttransplant infectious complications.</p>
</sec>
<sec id="section12-0148607112456041" sec-type="conclusions">
<title>Conclusions</title>
<p>Malnutrition is common in patients with liver cirrhosis undergoing liver resection or liver transplantation. Oral nutrition support with BCAA, synbiotics, and an immune-enhancing diet can have a beneficial effect on preventing the postoperative infections associated with hepatic resection or liver transplantation.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p>Financial disclosure: none declared.</p>
</fn>
<fn fn-type="supplementary-material">
<p>Supplementary material for this article is available on the <italic>Journal of Parenteral and Enteral Nutrition</italic> website at <ext-link ext-link-type="uri" xlink:href="http://jpen.sagepub.com/supplemental">http://jpen.sagepub.com/supplemental</ext-link>.</p>
</fn>
<fn fn-type="other">
<p>This article originally appeared online on August 16, 2012.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0148607112456041">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Brien</surname><given-names>A</given-names></name>
<name><surname>Williams</surname><given-names>R</given-names></name>
</person-group>. <article-title>Nutrition in end-stage liver disease: principles and practice</article-title>. <source>Gastroenterology</source>. <year>2008</year>;<volume>134</volume>(<issue>6</issue>):<fpage>1729</fpage>-<lpage>1740</lpage>.</citation>
</ref>
<ref id="bibr2-0148607112456041">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alberino</surname><given-names>F</given-names></name>
<name><surname>Gatta</surname><given-names>A</given-names></name>
<name><surname>Amodio</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Nutrition and survival in patients with liver cirrhosis</article-title>. <source>Nutrition</source>. <year>2001</year>;<volume>17</volume>(<issue>6</issue>):<fpage>445</fpage>-<lpage>450</lpage>.</citation>
</ref>
<ref id="bibr3-0148607112456041">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Caregaro</surname><given-names>L</given-names></name>
<name><surname>Alberino</surname><given-names>F</given-names></name>
<name><surname>Amodio</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Malnutrition in alcoholic and virus-related cirrhosis</article-title>. <source>Am J Clin Nutr</source>. <year>1996</year>;<volume>63</volume>(<issue>4</issue>):<fpage>602</fpage>-<lpage>609</lpage>.</citation>
</ref>
<ref id="bibr4-0148607112456041">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cordoba</surname><given-names>J</given-names></name>
<name><surname>Lopez-Hellin</surname><given-names>J</given-names></name>
<name><surname>Planas</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Normal protein diet for episodic hepatic encephalopathy: results of a randomized study</article-title>. <source>J Hepatol</source>. <year>2004</year>;<volume>41</volume>(<issue>1</issue>):<fpage>38</fpage>-<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr5-0148607112456041">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Donaghy</surname><given-names>A</given-names></name>
</person-group>. <article-title>Issues of malnutrition and bone disease in patients with cirrhosis</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2002</year>;<volume>17</volume>(<issue>4</issue>):<fpage>462</fpage>-<lpage>466</lpage>.</citation>
</ref>
<ref id="bibr6-0148607112456041">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Henkel</surname><given-names>AS</given-names></name>
<name><surname>Buchman</surname><given-names>AL</given-names></name>
</person-group>. <article-title>Nutritional support in patients with chronic liver disease</article-title>. <source>Nat Clin Pract Gastroenterol Hepatol</source>. <year>2006</year>;<volume>3</volume>(<issue>4</issue>):<fpage>202</fpage>-<lpage>209</lpage>.</citation>
</ref>
<ref id="bibr7-0148607112456041">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tsiaousi</surname><given-names>ET</given-names></name>
<name><surname>Hatzitolios</surname><given-names>AI</given-names></name>
<name><surname>Trygonis</surname><given-names>SK</given-names></name>
<name><surname>Savopoulos</surname><given-names>CG</given-names></name>
</person-group>. <article-title>Malnutrition in end stage liver disease: recommendations and nutritional support</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2008</year>;<volume>23</volume>(<issue>4</issue>):<fpage>527</fpage>-<lpage>533</lpage>.</citation>
</ref>
<ref id="bibr8-0148607112456041">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Merli</surname><given-names>M</given-names></name>
<name><surname>Nicolini</surname><given-names>G</given-names></name>
<name><surname>Angeloni</surname><given-names>S</given-names></name>
<name><surname>Riggio</surname><given-names>O</given-names></name>
</person-group>. <article-title>Malnutrition is a risk factor in cirrhotic patients undergoing surgery</article-title>. <source>Nutrition</source>. <year>2002</year>;<volume>18</volume>(<issue>11-12</issue>):<fpage>978</fpage>-<lpage>986</lpage>.</citation>
</ref>
<ref id="bibr9-0148607112456041">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pikul</surname><given-names>J</given-names></name>
<name><surname>Sharpe</surname><given-names>MD</given-names></name>
<name><surname>Lowndes</surname><given-names>R</given-names></name>
<name><surname>Ghent</surname><given-names>CN</given-names></name>
</person-group>. <article-title>Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients</article-title>. <source>Transplantation</source>. <year>1994</year>;<volume>57</volume>(<issue>3</issue>):<fpage>469</fpage>-<lpage>472</lpage>.</citation>
</ref>
<ref id="bibr10-0148607112456041">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ricci</surname><given-names>P</given-names></name>
<name><surname>Therneau</surname><given-names>TM</given-names></name>
<name><surname>Malinchoc</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease</article-title>. <source>Hepatology</source>. <year>1997</year>;<volume>25</volume>(<issue>3</issue>):<fpage>672</fpage>-<lpage>677</lpage>.</citation>
</ref>
<ref id="bibr11-0148607112456041">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Selberg</surname><given-names>O</given-names></name>
<name><surname>Bottcher</surname><given-names>J</given-names></name>
<name><surname>Tusch</surname><given-names>G</given-names></name>
<name><surname>Pichlmayr</surname><given-names>R</given-names></name>
<name><surname>Henkel</surname><given-names>E</given-names></name>
<name><surname>Muller</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients</article-title>. <source>Hepatology</source>. <year>1997</year>;<volume>25</volume>(<issue>3</issue>):<fpage>652</fpage>-<lpage>657</lpage>.</citation>
</ref>
<ref id="bibr12-0148607112456041">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Figueiredo</surname><given-names>F</given-names></name>
<name><surname>Dickson</surname><given-names>ER</given-names></name>
<name><surname>Pasha</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>Impact of nutritional status on outcomes after liver transplantation</article-title>. <source>Transplantation</source>. <year>2000</year>;<volume>70</volume>(<issue>9</issue>):<fpage>1347</fpage>-<lpage>1352</lpage>.</citation>
</ref>
<ref id="bibr13-0148607112456041">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shahid</surname><given-names>M</given-names></name>
<name><surname>Johnson</surname><given-names>J</given-names></name>
<name><surname>Nightingale</surname><given-names>P</given-names></name>
<name><surname>Neuberger</surname><given-names>J</given-names></name>
</person-group>. <article-title>Nutritional markers in liver allograft recipients</article-title>. <source>Transplantation</source>. <year>2005</year>;<volume>79</volume>(<issue>3</issue>):<fpage>359</fpage>-<lpage>362</lpage>.</citation>
</ref>
<ref id="bibr14-0148607112456041">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Calder</surname><given-names>PC</given-names></name>
</person-group>. <article-title>Branched-chain amino acids and immunity</article-title>. <source>J Nutr</source>. <year>2006</year>;<volume>136</volume>(<issue>1</issue>)(<supplement>suppl</supplement>):<fpage>288S</fpage>-<lpage>293S</lpage>.</citation>
</ref>
<ref id="bibr15-0148607112456041">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Choudry</surname><given-names>HA</given-names></name>
<name><surname>Pan</surname><given-names>M</given-names></name>
<name><surname>Karinch</surname><given-names>AM</given-names></name>
<name><surname>Souba</surname><given-names>WW</given-names></name>
</person-group>. <article-title>Branched-chain amino acid-enriched nutritional support in surgical and cancer patients</article-title>. <source>J Nutr</source>. <year>2006</year>;<volume>136</volume>(<issue>1</issue>)(<supplement>suppl</supplement>):<fpage>314S</fpage>-<lpage>318S</lpage>.</citation>
</ref>
<ref id="bibr16-0148607112456041">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Charlton</surname><given-names>M</given-names></name>
</person-group>. <article-title>Branched-chain amino acid enriched supplements as therapy for liver disease</article-title>. <source>J Nutr</source>. <year>2006</year>;<volume>136</volume>(<issue>1</issue>)(<supplement>suppl</supplement>):<fpage>295S</fpage>-<lpage>298S</lpage>.</citation>
</ref>
<ref id="bibr17-0148607112456041">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Holecek</surname><given-names>M</given-names></name>
</person-group>. <article-title>Three targets of branched-chain amino acid supplementation in the treatment of liver disease</article-title>. <source>Nutrition</source>. <year>2010</year>;<volume>26</volume>(<issue>5</issue>):<fpage>482</fpage>-<lpage>490</lpage>.</citation>
</ref>
<ref id="bibr18-0148607112456041">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Razonable</surname><given-names>RR</given-names></name>
<name><surname>Findlay</surname><given-names>JY</given-names></name>
<name><surname>O’Riordan</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Critical care issues in patients after liver transplantation</article-title>. <source>Liver Transpl</source>. <year>2011</year>;<volume>17</volume>(<issue>5</issue>):<fpage>511</fpage>-<lpage>527</lpage>.</citation>
</ref>
<ref id="bibr19-0148607112456041">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Merli</surname><given-names>M</given-names></name>
<name><surname>Giusto</surname><given-names>M</given-names></name>
<name><surname>Gentili</surname><given-names>F</given-names></name><etal/>
</person-group>. <article-title>Nutritional status: its influence on the outcome of patients undergoing liver transplantation</article-title>. <source>Liver Int</source>. <year>2010</year>;<volume>30</volume>(<issue>2</issue>):<fpage>208</fpage>-<lpage>214</lpage>.</citation>
</ref>
<ref id="bibr20-0148607112456041">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harrison</surname><given-names>J</given-names></name>
<name><surname>McKiernan</surname><given-names>J</given-names></name>
<name><surname>Neuberger</surname><given-names>JM</given-names></name>
</person-group>. <article-title>A prospective study on the effect of recipient nutritional status on outcome in liver transplantation</article-title>. <source>Transpl Int</source>. <year>1997</year>;<volume>10</volume>(<issue>5</issue>):<fpage>369</fpage>-<lpage>374</lpage>.</citation>
</ref>
<ref id="bibr21-0148607112456041">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaido</surname><given-names>T</given-names></name>
<name><surname>Mori</surname><given-names>A</given-names></name>
<name><surname>Oike</surname><given-names>F</given-names></name><etal/>
</person-group>. <article-title>Impact of pretransplant nutritional status in patients undergoing liver transplantation</article-title>. <source>Hepatogastroenterology</source>. <year>2010</year>;<volume>57</volume>(<issue>104</issue>):<fpage>1489</fpage>-<lpage>1492</lpage>.</citation>
</ref>
<ref id="bibr22-0148607112456041">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shirabe</surname><given-names>K</given-names></name>
<name><surname>Yoshimatsu</surname><given-names>M</given-names></name>
<name><surname>Motomura</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients</article-title>. <source>Liver Transpl</source>. <year>2011</year>;<volume>17</volume>(<issue>9</issue>):<fpage>1073</fpage>-<lpage>1080</lpage>.</citation>
</ref>
<ref id="bibr23-0148607112456041">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Singh</surname><given-names>N</given-names></name>
<name><surname>Paterson</surname><given-names>DL</given-names></name>
<name><surname>Gayowski</surname><given-names>T</given-names></name>
<name><surname>Wagener</surname><given-names>MM</given-names></name>
<name><surname>Marino</surname><given-names>IR</given-names></name>
</person-group>. <article-title>Predicting bacteremia and bacteremic mortality in liver transplant recipients</article-title>. <source>Liver Transpl</source>. <year>2000</year>;<volume>6</volume>(<issue>1</issue>):<fpage>54</fpage>-<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr24-0148607112456041">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Iida</surname><given-names>T</given-names></name>
<name><surname>Kaido</surname><given-names>T</given-names></name>
<name><surname>Yagi</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Posttransplant bacteremia in adult living donor liver transplant recipients</article-title>. <source>Liver Transpl</source>. <year>2010</year>;<volume>16</volume>(<issue>12</issue>):<fpage>1379</fpage>-<lpage>1385</lpage>.</citation>
</ref>
<ref id="bibr25-0148607112456041">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>SI</given-names></name>
<name><surname>Kim</surname><given-names>YJ</given-names></name>
<name><surname>Jun</surname><given-names>YH</given-names></name><etal/>
</person-group>. <article-title>Epidemiology and risk factors for bacteremia in 144 consecutive living-donor liver transplant recipients</article-title>. <source>Yonsei Med J</source>. <year>2009</year>;<volume>50</volume>(<issue>1</issue>):<fpage>112</fpage>-<lpage>121</lpage>.</citation>
</ref>
<ref id="bibr26-0148607112456041">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McCullough</surname><given-names>AJ</given-names></name>
<name><surname>Bugianesi</surname><given-names>E</given-names></name>
</person-group>. <article-title>Protein-calorie malnutrition and the etiology of cirrhosis</article-title>. <source>Am J Gastroenterol</source>. <year>1997</year>;<volume>92</volume>(<issue>5</issue>):<fpage>734</fpage>-<lpage>738</lpage>.</citation>
</ref>
<ref id="bibr27-0148607112456041">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cheung</surname><given-names>K</given-names></name>
<name><surname>Lee</surname><given-names>SS</given-names></name>
<name><surname>Raman</surname><given-names>M</given-names></name>
</person-group>. <article-title>Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies</article-title>. <source>Clin Gastroenterol Hepatol</source>. <year>2012</year>;<volume>10</volume>(<issue>2</issue>):<fpage>117</fpage>-<lpage>125</lpage>.</citation>
</ref>
<ref id="bibr28-0148607112456041">
<label>28.</label>
<citation citation-type="journal">
<collab>Nutritional status in cirrhosis</collab>. <article-title>Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis</article-title>. <source>J Hepatol</source>. <year>1994</year>;<volume>21</volume>(<issue>3</issue>):<fpage>317</fpage>-<lpage>325</lpage>.</citation>
</ref>
<ref id="bibr29-0148607112456041">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Christou</surname><given-names>L</given-names></name>
<name><surname>Pappas</surname><given-names>G</given-names></name>
<name><surname>Falagas</surname><given-names>ME</given-names></name>
</person-group>. <article-title>Bacterial infection-related morbidity and mortality in cirrhosis</article-title>. <source>Am J Gastroenterol</source>. <year>2007</year>;<volume>102</volume>(<issue>7</issue>):<fpage>1510</fpage>-<lpage>1517</lpage>.</citation>
</ref>
<ref id="bibr30-0148607112456041">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koulaouzidis</surname><given-names>A</given-names></name>
<name><surname>Bhat</surname><given-names>S</given-names></name>
<name><surname>Saeed</surname><given-names>AA</given-names></name>
</person-group>. <article-title>Spontaneous bacterial peritonitis</article-title>. <source>World J Gastroenterol</source>. <year>2009</year>;<volume>15</volume>(<issue>9</issue>):<fpage>1042</fpage>-<lpage>1049</lpage>.</citation>
</ref>
<ref id="bibr31-0148607112456041">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Campillo</surname><given-names>B</given-names></name>
<name><surname>Richardet</surname><given-names>JP</given-names></name>
<name><surname>Bories</surname><given-names>PN</given-names></name>
</person-group>. <article-title>Enteral nutrition in severely malnourished and anorectic cirrhotic patients in clinical practice</article-title>. <source>Gastroenterol Clin Biol</source>. <year>2005</year>;<volume>29</volume>(<issue>6-7</issue>):<fpage>645</fpage>-<lpage>651</lpage>.</citation>
</ref>
<ref id="bibr32-0148607112456041">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Plauth</surname><given-names>M</given-names></name>
<name><surname>Cabre</surname><given-names>E</given-names></name>
<name><surname>Riggio</surname><given-names>O</given-names></name><etal/>
</person-group>. <article-title>ESPEN guidelines on enteral nutrition: liver disease</article-title>. <source>Clin Nutr</source>. <year>2006</year>;<volume>25</volume>(<issue>2</issue>):<fpage>285</fpage>-<lpage>294</lpage>.</citation>
</ref>
<ref id="bibr33-0148607112456041">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Durnin</surname><given-names>JV</given-names></name>
<name><surname>Womersley</surname><given-names>J</given-names></name>
</person-group>. <article-title>Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years</article-title>. <source>Br J Nutr</source>. <year>1974</year>;<volume>32</volume>(<issue>1</issue>):<fpage>77</fpage>-<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr34-0148607112456041">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Frisancho</surname><given-names>AR</given-names></name>
</person-group>. <article-title>New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly</article-title>. <source>Am J Clin Nutr</source>. <year>1984</year>;<volume>40</volume>(<issue>4</issue>):<fpage>808</fpage>-<lpage>819</lpage>.</citation>
</ref>
<ref id="bibr35-0148607112456041">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hasse</surname><given-names>J</given-names></name>
<name><surname>Strong</surname><given-names>S</given-names></name>
<name><surname>Gorman</surname><given-names>MA</given-names></name>
<name><surname>Liepa</surname><given-names>G</given-names></name>
</person-group>. <article-title>Subjective global assessment: alternative nutrition-assessment technique for liver-transplant candidates</article-title>. <source>Nutrition</source>. <year>1993</year>;<volume>9</volume>(<issue>4</issue>):<fpage>339</fpage>-<lpage>343</lpage>.</citation>
</ref>
<ref id="bibr36-0148607112456041">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Detsky</surname><given-names>AS</given-names></name>
<name><surname>McLaughlin</surname><given-names>JR</given-names></name>
<name><surname>Baker</surname><given-names>JP</given-names></name><etal/>
</person-group>. <article-title>What is subjective global assessment of nutritional status?</article-title> <source>JPEN J Parenter Enteral Nutr</source>. <year>1987</year>;<volume>11</volume>(<issue>1</issue>):<fpage>8</fpage>-<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr37-0148607112456041">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stephenson</surname><given-names>GR</given-names></name>
<name><surname>Moretti</surname><given-names>EW</given-names></name>
<name><surname>El-Moalem</surname><given-names>H</given-names></name>
<name><surname>Clavien</surname><given-names>PA</given-names></name>
<name><surname>Tuttle-Newhall</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Malnutrition in liver transplant patients: preoperative subjective global assessment is predictive of outcome after liver transplantation</article-title>. <source>Transplantation</source>. <year>2001</year>;<volume>72</volume>(<issue>4</issue>):<fpage>666</fpage>-<lpage>670</lpage>.</citation>
</ref>
<ref id="bibr38-0148607112456041">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gunsar</surname><given-names>F</given-names></name>
<name><surname>Raimondo</surname><given-names>ML</given-names></name>
<name><surname>Jones</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Nutritional status and prognosis in cirrhotic patients</article-title>. <source>Aliment Pharmacol Ther</source>. <year>2006</year>;<volume>24</volume>(<issue>4</issue>):<fpage>563</fpage>-<lpage>572</lpage>.</citation>
</ref>
<ref id="bibr39-0148607112456041">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morgan</surname><given-names>MY</given-names></name>
<name><surname>Madden</surname><given-names>AM</given-names></name>
<name><surname>Soulsby</surname><given-names>CT</given-names></name>
<name><surname>Morris</surname><given-names>RW</given-names></name>
</person-group>. <article-title>Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis</article-title>. <source>Hepatology</source>. <year>2006</year>;<volume>44</volume>(<issue>4</issue>):<fpage>823</fpage>-<lpage>835</lpage>.</citation>
</ref>
<ref id="bibr40-0148607112456041">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alvares-da-Silva</surname><given-names>MR</given-names></name>
<name><surname>Reverbel</surname><given-names>da</given-names></name>
<name><surname>Silveira</surname><given-names>T</given-names></name>
</person-group>. <article-title>Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients</article-title>. <source>Nutrition</source>. <year>2005</year>;<volume>21</volume>(<issue>2</issue>):<fpage>113</fpage>-<lpage>117</lpage>.</citation>
</ref>
<ref id="bibr41-0148607112456041">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Montano-Loza</surname><given-names>A</given-names></name>
<name><surname>Meza-Junco</surname><given-names>J</given-names></name>
<name><surname>Prado</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Muscle wasting is associated with mortality in patients with cirrhosis</article-title>. <source>Clin Gastroenterol Hepatol</source>. <year>2012</year>;<volume>10</volume>(<issue>2</issue>):<fpage>166</fpage>-<lpage>173</lpage>.</citation>
</ref>
<ref id="bibr42-0148607112456041">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Englesbe</surname><given-names>MJ</given-names></name>
<name><surname>Patel</surname><given-names>SP</given-names></name>
<name><surname>He</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>Sarcopenia and mortality after liver transplantation</article-title>. <source>J Am Coll Surg</source>. <year>2010</year>;<volume>211</volume>(<issue>2</issue>):<fpage>271</fpage>-<lpage>278</lpage>.</citation>
</ref>
<ref id="bibr43-0148607112456041">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mattox</surname><given-names>TW</given-names></name>
<name><surname>Teasley-Strausburg</surname><given-names>KM</given-names></name>
</person-group>. <article-title>Overview of biochemical markers used for nutrition support</article-title>. <source>DICP</source>. <year>1991</year>;<volume>25</volume>(<issue>3</issue>):<fpage>265</fpage>-<lpage>271</lpage>.</citation>
</ref>
<ref id="bibr44-0148607112456041">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Muller</surname><given-names>MJ</given-names></name>
<name><surname>Lautz</surname><given-names>HU</given-names></name>
<name><surname>Plogmann</surname><given-names>B</given-names></name>
<name><surname>Burger</surname><given-names>M</given-names></name>
<name><surname>Korber</surname><given-names>J</given-names></name>
<name><surname>Schmidt</surname><given-names>FW</given-names></name>
</person-group>. <article-title>Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state</article-title>. <source>Hepatology</source>. <year>1992</year>;<volume>15</volume>(<issue>5</issue>):<fpage>782</fpage>-<lpage>794</lpage>.</citation>
</ref>
<ref id="bibr45-0148607112456041">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pirlich</surname><given-names>M</given-names></name>
<name><surname>Schutz</surname><given-names>T</given-names></name>
<name><surname>Spachos</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites</article-title>. <source>Hepatology</source>. <year>2000</year>;<volume>32</volume>(<issue>6</issue>):<fpage>1208</fpage>-<lpage>1215</lpage>.</citation>
</ref>
<ref id="bibr46-0148607112456041">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Smith</surname><given-names>FR</given-names></name>
<name><surname>Suskind</surname><given-names>R</given-names></name>
<name><surname>Thanangkul</surname><given-names>O</given-names></name>
<name><surname>Leitzmann</surname><given-names>C</given-names></name>
<name><surname>Goodman</surname><given-names>DS</given-names></name>
<name><surname>Olson</surname><given-names>RE</given-names></name>
</person-group>. <article-title>Plasma vitamin A, retinol-binding protein and prealbumin concentrations in protein-calorie malnutrition, III: response to varying dietary treatments</article-title>. <source>Am J Clin Nutr</source>. <year>1975</year>;<volume>28</volume>(<issue>7</issue>):<fpage>732</fpage>-<lpage>738</lpage>.</citation>
</ref>
<ref id="bibr47-0148607112456041">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yovita</surname><given-names>H</given-names></name>
<name><surname>Djumhana</surname><given-names>A</given-names></name>
<name><surname>Abdurachman</surname><given-names>SA</given-names></name>
<name><surname>Saketi</surname><given-names>JR</given-names></name>
</person-group>. <article-title>Correlation between anthropometrics measurements, prealbumin level and transferin serum with Child-Pugh classification in evaluating nutritional status of liver cirrhosis patient</article-title>. <source>Acta Med Indones</source>. <year>2004</year>;<volume>36</volume>(<issue>4</issue>):<fpage>197</fpage>-<lpage>201</lpage>.</citation>
</ref>
<ref id="bibr48-0148607112456041">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bemeur</surname><given-names>C</given-names></name>
<name><surname>Desjardins</surname><given-names>P</given-names></name>
<name><surname>Butterworth</surname><given-names>RF</given-names></name>
</person-group>. <article-title>Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure</article-title>. <source>J Nutr Metab</source>. <year>2010</year>;<volume>2010</volume>:<fpage>489823</fpage>.</citation>
</ref>
<ref id="bibr49-0148607112456041">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McCluskey</surname><given-names>SA</given-names></name>
<name><surname>Karkouti</surname><given-names>K</given-names></name>
<name><surname>Wijeysundera</surname><given-names>DN</given-names></name><etal/>
</person-group>. <article-title>Derivation of a risk index for the prediction of massive blood transfusion in liver transplantation</article-title>. <source>Liver Transpl</source>. <year>2006</year>;<volume>12</volume>(<issue>11</issue>):<fpage>1584</fpage>-<lpage>1593</lpage>.</citation>
</ref>
<ref id="bibr50-0148607112456041">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fusai</surname><given-names>G</given-names></name>
<name><surname>Dhaliwal</surname><given-names>P</given-names></name>
<name><surname>Rolando</surname><given-names>N</given-names></name><etal/>
</person-group>. <article-title>Incidence and risk factors for the development of prolonged and severe intrahepatic cholestasis after liver transplantation</article-title>. <source>Liver Transpl</source>. <year>2006</year>;<volume>12</volume>(<issue>11</issue>):<fpage>1626</fpage>-<lpage>1633</lpage>.</citation>
</ref>
<ref id="bibr51-0148607112456041">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Piquet</surname><given-names>MA</given-names></name>
<name><surname>Ollivier</surname><given-names>I</given-names></name>
<name><surname>Gloro</surname><given-names>R</given-names></name>
<name><surname>Castel</surname><given-names>H</given-names></name>
<name><surname>Tiengou</surname><given-names>LE</given-names></name>
<name><surname>Dao</surname><given-names>T</given-names></name>
</person-group>. <article-title>Nutritional indices in cirrhotic patients</article-title>. <source>Nutrition</source>. <year>2006</year>;<volume>22</volume>(<issue>2</issue>):<fpage>216</fpage>-<lpage>217</lpage>; author reply 218-219.</citation>
</ref>
<ref id="bibr52-0148607112456041">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dejong</surname><given-names>CH</given-names></name>
<name><surname>van</surname><given-names>de</given-names></name>
<name><surname>Poll</surname><given-names>MC</given-names></name>
<name><surname>Soeters</surname><given-names>PB</given-names></name>
<name><surname>Jalan</surname><given-names>R</given-names></name>
<name><surname>Olde Damink</surname><given-names>SW</given-names></name>
</person-group>. <article-title>Aromatic amino acid metabolism during liver failure</article-title>. <source>J Nutr</source>. <year>2007</year>;<volume>137</volume>(<issue>6</issue>)(<supplement>suppl 1</supplement>):<fpage>1579S</fpage>-<lpage>1585S</lpage>; discussion 1597S-1598S.</citation>
</ref>
<ref id="bibr53-0148607112456041">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tsuchiya</surname><given-names>M</given-names></name>
<name><surname>Sakaida</surname><given-names>I</given-names></name>
<name><surname>Okamoto</surname><given-names>M</given-names></name>
<name><surname>Okita</surname><given-names>K</given-names></name>
</person-group>. <article-title>The effect of a late evening snack in patients with liver cirrhosis</article-title>. <source>Hepatol Res</source>. <year>2005</year>;<volume>31</volume>(<issue>2</issue>):<fpage>95</fpage>-<lpage>103</lpage>.</citation>
</ref>
<ref id="bibr54-0148607112456041">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Matthews</surname><given-names>DR</given-names></name>
<name><surname>Hosker</surname><given-names>JP</given-names></name>
<name><surname>Rudenski</surname><given-names>AS</given-names></name>
<name><surname>Naylor</surname><given-names>BA</given-names></name>
<name><surname>Treacher</surname><given-names>DF</given-names></name>
<name><surname>Turner</surname><given-names>RC</given-names></name>
</person-group>. <article-title>Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man</article-title>. <source>Diabetologia</source>. <year>1985</year>;<volume>28</volume>(<issue>7</issue>):<fpage>412</fpage>-<lpage>419</lpage>.</citation>
</ref>
<ref id="bibr55-0148607112456041">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Catalano</surname><given-names>D</given-names></name>
<name><surname>Trovato</surname><given-names>GM</given-names></name>
<name><surname>Martines</surname><given-names>GF</given-names></name>
<name><surname>Randazzo</surname><given-names>M</given-names></name>
<name><surname>Tonzuso</surname><given-names>A</given-names></name>
</person-group>. <article-title>Bright liver, body composition and insulin resistance changes with nutritional intervention: a follow-up study</article-title>. <source>Liver Int</source>. <year>2008</year>;<volume>28</volume>(<issue>9</issue>):<fpage>1280</fpage>-<lpage>1287</lpage>.</citation>
</ref>
<ref id="bibr56-0148607112456041">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rigotti</surname><given-names>P</given-names></name>
<name><surname>Peters</surname><given-names>JC</given-names></name>
<name><surname>Tranberg</surname><given-names>KG</given-names></name>
<name><surname>Fischer</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Effects of amino acid infusions on liver regeneration after partial hepatectomy in the rat</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>1986</year>;<volume>10</volume>(<issue>1</issue>):<fpage>17</fpage>-<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr57-0148607112456041">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fan</surname><given-names>ST</given-names></name>
<name><surname>Lo</surname><given-names>CM</given-names></name>
<name><surname>Lai</surname><given-names>EC</given-names></name>
<name><surname>Chu</surname><given-names>KM</given-names></name>
<name><surname>Liu</surname><given-names>CL</given-names></name>
<name><surname>Wong</surname><given-names>J</given-names></name>
</person-group>. <article-title>Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma</article-title>. <source>N Engl J Med</source>. <year>1994</year>;<volume>331</volume>(<issue>23</issue>):<fpage>1547</fpage>-<lpage>1552</lpage>.</citation>
</ref>
<ref id="bibr58-0148607112456041">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Plauth</surname><given-names>M</given-names></name>
<name><surname>Cabre</surname><given-names>E</given-names></name>
<name><surname>Campillo</surname><given-names>B</given-names></name><etal/>
</person-group>. <article-title>ESPEN guidelines on parenteral nutrition: hepatology</article-title>. <source>Clin Nutr</source>. <year>2009</year>;<volume>28</volume>(<issue>4</issue>):<fpage>436</fpage>-<lpage>444</lpage>.</citation>
</ref>
<ref id="bibr59-0148607112456041">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wicks</surname><given-names>C</given-names></name>
<name><surname>Somasundaram</surname><given-names>S</given-names></name>
<name><surname>Bjarnason</surname><given-names>I</given-names></name><etal/>
</person-group>. <article-title>Comparison of enteral feeding and total parenteral nutrition after liver transplantation</article-title>. <source>Lancet</source>. <year>1994</year>;<volume>344</volume>(<issue>8926</issue>):<fpage>837</fpage>-<lpage>840</lpage>.</citation>
</ref>
<ref id="bibr60-0148607112456041">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Plauth</surname><given-names>M</given-names></name>
<name><surname>Roske</surname><given-names>AE</given-names></name>
<name><surname>Romaniuk</surname><given-names>P</given-names></name>
<name><surname>Roth</surname><given-names>E</given-names></name>
<name><surname>Ziebig</surname><given-names>R</given-names></name>
<name><surname>Lochs</surname><given-names>H</given-names></name>
</person-group>. <article-title>Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration</article-title>. <source>Gut</source>. <year>2000</year>;<volume>46</volume>(<issue>6</issue>):<fpage>849</fpage>-<lpage>855</lpage>.</citation>
</ref>
<ref id="bibr61-0148607112456041">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heyman</surname><given-names>JK</given-names></name>
<name><surname>Whitfield</surname><given-names>CJ</given-names></name>
<name><surname>Brock</surname><given-names>KE</given-names></name>
<name><surname>McCaughan</surname><given-names>GW</given-names></name>
<name><surname>Donaghy</surname><given-names>AJ</given-names></name>
</person-group>. <article-title>Dietary protein intakes in patients with hepatic encephalopathy and cirrhosis: current practice in NSW and ACT</article-title>. <source>Med J Aust</source>. <year>2006</year>;<volume>185</volume>(<issue>10</issue>):<fpage>542</fpage>-<lpage>543</lpage>.</citation>
</ref>
<ref id="bibr62-0148607112456041">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hirsch</surname><given-names>S</given-names></name>
<name><surname>Bunout</surname><given-names>D</given-names></name>
<name><surname>de</surname><given-names>la</given-names></name>
<name><surname>Maza</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>1993</year>;<volume>17</volume>(<issue>2</issue>):<fpage>119</fpage>-<lpage>124</lpage>.</citation>
</ref>
<ref id="bibr63-0148607112456041">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hirsch</surname><given-names>S</given-names></name>
<name><surname>de</surname><given-names>la</given-names></name>
<name><surname>Maza</surname><given-names>MP</given-names></name>
<name><surname>Gattas</surname><given-names>V</given-names></name><etal/>
</person-group>. <article-title>Nutritional support in alcoholic cirrhotic patients improves host defenses</article-title>. <source>J Am Coll Nutr</source>. <year>1999</year>;<volume>18</volume>(<issue>5</issue>):<fpage>434</fpage>-<lpage>441</lpage>.</citation>
</ref>
<ref id="bibr64-0148607112456041">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mendenhall</surname><given-names>CL</given-names></name>
<name><surname>Moritz</surname><given-names>TE</given-names></name>
<name><surname>Roselle</surname><given-names>GA</given-names></name><etal/>
</person-group>. <article-title>A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study</article-title>. <source>Hepatology</source>. <year>1993</year>;<volume>17</volume>(<issue>4</issue>):<fpage>564</fpage>-<lpage>576</lpage>.</citation>
</ref>
<ref id="bibr65-0148607112456041">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kearns</surname><given-names>PJ</given-names></name>
<name><surname>Young</surname><given-names>H</given-names></name>
<name><surname>Garcia</surname><given-names>G</given-names></name><etal/>
</person-group>. <article-title>Accelerated improvement of alcoholic liver disease with enteral nutrition</article-title>. <source>Gastroenterology</source>. <year>1992</year>;<volume>102</volume>(<issue>1</issue>):<fpage>200</fpage>-<lpage>205</lpage>.</citation>
</ref>
<ref id="bibr66-0148607112456041">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cabre</surname><given-names>E</given-names></name>
<name><surname>Gonzalez-Huix</surname><given-names>F</given-names></name>
<name><surname>Abad-Lacruz</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics: a randomized controlled trial</article-title>. <source>Gastroenterology</source>. <year>1990</year>;<volume>98</volume>(<issue>3</issue>):<fpage>715</fpage>-<lpage>720</lpage>.</citation>
</ref>
<ref id="bibr67-0148607112456041">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Le Cornu</surname><given-names>KA</given-names></name>
<name><surname>McKiernan</surname><given-names>FJ</given-names></name>
<name><surname>Kapadia</surname><given-names>SA</given-names></name>
<name><surname>Neuberger</surname><given-names>JM</given-names></name>
</person-group>. <article-title>A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation</article-title>. <source>Transplantation</source>. <year>2000</year>;<volume>69</volume>(<issue>7</issue>):<fpage>1364</fpage>-<lpage>1369</lpage>.</citation>
</ref>
<ref id="bibr68-0148607112456041">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Richter</surname><given-names>B</given-names></name>
<name><surname>Schmandra</surname><given-names>TC</given-names></name>
<name><surname>Golling</surname><given-names>M</given-names></name>
<name><surname>Bechstein</surname><given-names>WO</given-names></name>
</person-group>. <article-title>Nutritional support after open liver resection: a systematic review</article-title>. <source>Dig Surg</source>. <year>2006</year>;<volume>23</volume>(<issue>3</issue>):<fpage>139</fpage>-<lpage>145</lpage>.</citation>
</ref>
<ref id="bibr69-0148607112456041">
<label>69.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shirabe</surname><given-names>K</given-names></name>
<name><surname>Matsumata</surname><given-names>T</given-names></name>
<name><surname>Shimada</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>A comparison of parenteral hyperalimentation and early enteral feeding regarding systemic immunity after major hepatic resection—the results of a randomized prospective study</article-title>. <source>Hepatogastroenterology</source>. <year>1997</year>;<volume>44</volume>(<issue>13</issue>):<fpage>205</fpage>-<lpage>209</lpage>.</citation>
</ref>
<ref id="bibr70-0148607112456041">
<label>70.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mochizuki</surname><given-names>H</given-names></name>
<name><surname>Togo</surname><given-names>S</given-names></name>
<name><surname>Tanaka</surname><given-names>K</given-names></name>
<name><surname>Endo</surname><given-names>I</given-names></name>
<name><surname>Shimada</surname><given-names>H</given-names></name>
</person-group>. <article-title>Early enteral nutrition after hepatectomy to prevent postoperative infection</article-title>. <source>Hepatogastroenterology</source>. <year>2000</year>;<volume>47</volume>(<issue>35</issue>):<fpage>1407</fpage>-<lpage>1410</lpage>.</citation>
</ref>
<ref id="bibr71-0148607112456041">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>August</surname><given-names>DA</given-names></name>
<name><surname>Huhmann</surname><given-names>MB</given-names></name>
</person-group>. <article-title>A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2009</year>;<volume>33</volume>(<issue>5</issue>):<fpage>472</fpage>-<lpage>500</lpage>.</citation>
</ref>
<ref id="bibr72-0148607112456041">
<label>72.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaido</surname><given-names>T</given-names></name>
<name><surname>Egawa</surname><given-names>H</given-names></name>
<name><surname>Tsuji</surname><given-names>H</given-names></name>
<name><surname>Ashihara</surname><given-names>E</given-names></name>
<name><surname>Maekawa</surname><given-names>T</given-names></name>
<name><surname>Uemoto</surname><given-names>S</given-names></name>
</person-group>. <article-title>In-hospital mortality in adult recipients of living donor liver transplantation: experience of 576 consecutive cases at a single center</article-title>. <source>Liver Transpl</source>. <year>2009</year>;<volume>15</volume>(<issue>11</issue>):<fpage>1420</fpage>-<lpage>1425</lpage>.</citation>
</ref>
<ref id="bibr73-0148607112456041">
<label>73.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rondanelli</surname><given-names>M</given-names></name>
<name><surname>Opizzi</surname><given-names>A</given-names></name>
<name><surname>Antoniello</surname><given-names>N</given-names></name><etal/>
</person-group>. <article-title>Effect of essential amino acid supplementation on quality of life, amino acid profile and strength in institutionalized elderly patients</article-title>. <source>Clin Nutr</source>. <year>2011</year>;<volume>30</volume>(<issue>5</issue>):<fpage>571</fpage>-<lpage>577</lpage>.</citation>
</ref>
<ref id="bibr74-0148607112456041">
<label>74.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Als-Nielsen</surname><given-names>B</given-names></name>
<name><surname>Koretz</surname><given-names>RL</given-names></name>
<name><surname>Kjaergard</surname><given-names>LL</given-names></name>
<name><surname>Gluud</surname><given-names>C</given-names></name>
</person-group>. <article-title>Branched-chain amino acids for hepatic encephalopathy</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2003</year>;(<issue>2</issue>):CD001939.</citation>
</ref>
<ref id="bibr75-0148607112456041">
<label>75.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marchesini</surname><given-names>G</given-names></name>
<name><surname>Bianchi</surname><given-names>G</given-names></name>
<name><surname>Merli</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial</article-title>. <source>Gastroenterology</source>. <year>2003</year>;<volume>124</volume>(<issue>7</issue>):<fpage>1792</fpage>-<lpage>1801</lpage>.</citation>
</ref>
<ref id="bibr76-0148607112456041">
<label>76.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moriwaki</surname><given-names>H</given-names></name>
<name><surname>Shiraki</surname><given-names>M</given-names></name>
<name><surname>Fukushima</surname><given-names>H</given-names></name><etal/>
</person-group>. <article-title>Long-term outcome of branched-chain amino acid treatment in patients with liver cirrhosis</article-title>. <source>Hepatol Res</source>. <year>2008</year>;<volume>38</volume>(<supplement>suppl 1</supplement>):<fpage>S102</fpage>-<lpage>S106</lpage>.</citation>
</ref>
<ref id="bibr77-0148607112456041">
<label>77.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nakaya</surname><given-names>Y</given-names></name>
<name><surname>Okita</surname><given-names>K</given-names></name>
<name><surname>Suzuki</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>BCAA-enriched snack improves nutritional state of cirrhosis</article-title>. <source>Nutrition</source>. <year>2007</year>;<volume>23</volume>(<issue>2</issue>):<fpage>113</fpage>-<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr78-0148607112456041">
<label>78.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kobayashi</surname><given-names>M</given-names></name>
<name><surname>Ikeda</surname><given-names>K</given-names></name>
<name><surname>Arase</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus</article-title>. <source>J Gastroenterol</source>. <year>2008</year>;<volume>43</volume>(<issue>1</issue>):<fpage>63</fpage>-<lpage>70</lpage>.</citation>
</ref>
<ref id="bibr79-0148607112456041">
<label>79.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Habu</surname><given-names>D</given-names></name>
<name><surname>Nishiguchi</surname><given-names>S</given-names></name>
<name><surname>Nakatani</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis</article-title>. <source>Hepatogastroenterology</source>. <year>2009</year>;<volume>56</volume>(<issue>96</issue>):<fpage>1719</fpage>-<lpage>1723</lpage>.</citation>
</ref>
<ref id="bibr80-0148607112456041">
<label>80.</label>
<citation citation-type="journal">
<article-title>Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial</article-title>. <collab>The San-in Group of Liver Surgery</collab>. <source>Br J Surg</source>. <year>1997</year>;<volume>84</volume>(<issue>11</issue>):<fpage>1525</fpage>-<lpage>1531</lpage>.</citation>
</ref>
<ref id="bibr81-0148607112456041">
<label>81.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Meng</surname><given-names>WC</given-names></name>
<name><surname>Leung</surname><given-names>KL</given-names></name>
<name><surname>Ho</surname><given-names>RL</given-names></name>
<name><surname>Leung</surname><given-names>TW</given-names></name>
<name><surname>Lau</surname><given-names>WY</given-names></name>
</person-group>. <article-title>Prospective randomized control study on the effect of branched-chain amino acids in patients with liver resection for hepatocellular carcinoma</article-title>. <source>Aust N Z J Surg</source>. <year>1999</year>;<volume>69</volume>(<issue>11</issue>):<fpage>811</fpage>-<lpage>815</lpage>.</citation>
</ref>
<ref id="bibr82-0148607112456041">
<label>82.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Poon</surname><given-names>RT</given-names></name>
<name><surname>Yu</surname><given-names>WC</given-names></name>
<name><surname>Fan</surname><given-names>ST</given-names></name>
<name><surname>Wong</surname><given-names>J</given-names></name>
</person-group>. <article-title>Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial</article-title>. <source>Aliment Pharmacol Ther</source>. <year>2004</year>;<volume>19</volume>(<issue>7</issue>):<fpage>779</fpage>-<lpage>788</lpage>.</citation>
</ref>
<ref id="bibr83-0148607112456041">
<label>83.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Takeshita</surname><given-names>S</given-names></name>
<name><surname>Ichikawa</surname><given-names>T</given-names></name>
<name><surname>Nakao</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma</article-title>. <source>Nutr Res</source>. <year>2009</year>;<volume>29</volume>(<issue>2</issue>):<fpage>89</fpage>-<lpage>93</lpage>.</citation>
</ref>
<ref id="bibr84-0148607112456041">
<label>84.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ishikawa</surname><given-names>T</given-names></name>
<name><surname>Michitaka</surname><given-names>I</given-names></name>
<name><surname>Kamimura</surname><given-names>H</given-names></name><etal/>
</person-group>. <article-title>Oral branched-chain amino acids administration improves impaired liver dysfunction after radiofrequency ablation therapy for hepatocellular carcinoma</article-title>. <source>Hepatogastroenterology</source>. <year>2009</year>;<volume>56</volume>(<issue>94-95</issue>):<fpage>1491</fpage>-<lpage>1495</lpage>.</citation>
</ref>
<ref id="bibr85-0148607112456041">
<label>85.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuroda</surname><given-names>H</given-names></name>
<name><surname>Ushio</surname><given-names>A</given-names></name>
<name><surname>Miyamoto</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>Effects of branched-chain amino acid-enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: a one-year prospective trial</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2010</year>;<volume>25</volume>(<issue>9</issue>):<fpage>1550</fpage>-<lpage>1555</lpage>.</citation>
</ref>
<ref id="bibr86-0148607112456041">
<label>86.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Iwasa</surname><given-names>M</given-names></name>
<name><surname>Matsumura</surname><given-names>K</given-names></name>
<name><surname>Watanabe</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis</article-title>. <source>Eur J Gastroenterol Hepatol</source>. <year>2003</year>;<volume>15</volume>(<issue>7</issue>):<fpage>733</fpage>-<lpage>737</lpage>.</citation>
</ref>
<ref id="bibr87-0148607112456041">
<label>87.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Muto</surname><given-names>Y</given-names></name>
<name><surname>Sato</surname><given-names>S</given-names></name>
<name><surname>Watanabe</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis</article-title>. <source>Clin Gastroenterol Hepatol</source>. <year>2005</year>;<volume>3</volume>(<issue>7</issue>):<fpage>705</fpage>-<lpage>713</lpage>.</citation>
</ref>
<ref id="bibr88-0148607112456041">
<label>88.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fukushima</surname><given-names>H</given-names></name>
<name><surname>Miwa</surname><given-names>Y</given-names></name>
<name><surname>Ida</surname><given-names>E</given-names></name><etal/>
</person-group>. <article-title>Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: comparison with daytime administration</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2003</year>;<volume>27</volume>(<issue>5</issue>):<fpage>315</fpage>-<lpage>322</lpage>.</citation>
</ref>
<ref id="bibr89-0148607112456041">
<label>89.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bianchi</surname><given-names>G</given-names></name>
<name><surname>Marzocchi</surname><given-names>R</given-names></name>
<name><surname>Agostini</surname><given-names>F</given-names></name>
<name><surname>Marchesini</surname><given-names>G</given-names></name>
</person-group>. <article-title>Update on nutritional supplementation with branched-chain amino acids</article-title>. <source>Curr Opin Clin Nutr Metab Care</source>. <year>2005</year>;<volume>8</volume>(<issue>1</issue>):<fpage>83</fpage>-<lpage>87</lpage>.</citation>
</ref>
<ref id="bibr90-0148607112456041">
<label>90.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Urata</surname><given-names>Y</given-names></name>
<name><surname>Okita</surname><given-names>K</given-names></name>
<name><surname>Korenaga</surname><given-names>K</given-names></name>
<name><surname>Uchida</surname><given-names>K</given-names></name>
<name><surname>Yamasaki</surname><given-names>T</given-names></name>
<name><surname>Sakaida</surname><given-names>I</given-names></name>
</person-group>. <article-title>The effect of supplementation with branched-chain amino acids in patients with liver cirrhosis</article-title>. <source>Hepatol Res</source>. <year>2007</year>;<volume>37</volume>(<issue>7</issue>):<fpage>510</fpage>-<lpage>516</lpage>.</citation>
</ref>
<ref id="bibr91-0148607112456041">
<label>91.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Suzuki</surname><given-names>K</given-names></name>
<name><surname>Kagawa</surname><given-names>K</given-names></name>
<name><surname>Koizumi</surname><given-names>K</given-names></name>
<name><surname>Katayama</surname><given-names>H</given-names></name>
<name><surname>Sugawara</surname><given-names>M</given-names></name>
</person-group>. <article-title>Effects of late evening snack on diurnal plasma glucose profile in patients with chronic viral liver disease</article-title>. <source>Hepatol Res</source>. <year>2010</year>;<volume>40</volume>(<issue>9</issue>):<fpage>887</fpage>-<lpage>893</lpage>.</citation>
</ref>
<ref id="bibr92-0148607112456041">
<label>92.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Okabayashi</surname><given-names>T</given-names></name>
<name><surname>Nishimori</surname><given-names>I</given-names></name>
<name><surname>Yamashita</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>Preoperative oral supplementation with carbohydrate and branched-chain amino acid-enriched nutrient improves insulin resistance in patients undergoing a hepatectomy: a randomized clinical trial using an artificial pancreas</article-title>. <source>Amino Acids</source>. <year>2010</year>;<volume>38</volume>(<issue>3</issue>):<fpage>901</fpage>-<lpage>907</lpage>.</citation>
</ref>
<ref id="bibr93-0148607112456041">
<label>93.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Okamoto</surname><given-names>M</given-names></name>
<name><surname>Sakaida</surname><given-names>I</given-names></name>
<name><surname>Tsuchiya</surname><given-names>M</given-names></name>
<name><surname>Suzuki</surname><given-names>C</given-names></name>
<name><surname>Okita</surname><given-names>K</given-names></name>
</person-group>. <article-title>Effect of a late evening snack on the blood glucose level and energy metabolism in patients with liver cirrhosis</article-title>. <source>Hepatol Res</source>. <year>2003</year>;<volume>27</volume>(<issue>1</issue>):<fpage>45</fpage>-<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr94-0148607112456041">
<label>94.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aoyama</surname><given-names>K</given-names></name>
<name><surname>Tsuchiya</surname><given-names>M</given-names></name>
<name><surname>Mori</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>Effect of a late evening snack on outpatients with liver cirrhosis</article-title>. <source>Hepatol Res</source>. <year>2007</year>;<volume>37</volume>(<issue>8</issue>):<fpage>608</fpage>-<lpage>614</lpage>.</citation>
</ref>
<ref id="bibr95-0148607112456041">
<label>95.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sakaida</surname><given-names>I</given-names></name>
<name><surname>Tsuchiya</surname><given-names>M</given-names></name>
<name><surname>Okamoto</surname><given-names>M</given-names></name>
<name><surname>Okita</surname><given-names>K</given-names></name>
</person-group>. <article-title>Late evening snack and the change of blood glucose level in patients with liver cirrhosis</article-title>. <source>Hepatol Res</source>. <year>2004</year>;30S:<fpage>67</fpage>-<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr96-0148607112456041">
<label>96.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Okabayashi</surname><given-names>T</given-names></name>
<name><surname>Iyoki</surname><given-names>M</given-names></name>
<name><surname>Sugimoto</surname><given-names>T</given-names></name>
<name><surname>Kobayashi</surname><given-names>M</given-names></name>
<name><surname>Hanazaki</surname><given-names>K</given-names></name>
</person-group>. <article-title>Oral supplementation with carbohydrate- and branched-chain amino acid-enriched nutrients improves postoperative quality of life in patients undergoing hepatic resection</article-title>. <source>Amino Acids</source>. <year>2011</year>;<volume>40</volume>(<issue>4</issue>):<fpage>1213</fpage>-<lpage>1220</lpage>.</citation>
</ref>
<ref id="bibr97-0148607112456041">
<label>97.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Togo</surname><given-names>S</given-names></name>
<name><surname>Tanaka</surname><given-names>K</given-names></name>
<name><surname>Morioka</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>Usefulness of granular BCAA after hepatectomy for liver cancer complicated with liver cirrhosis</article-title>. <source>Nutrition</source>. <year>2005</year>;<volume>21</volume>(<issue>4</issue>):<fpage>480</fpage>-<lpage>486</lpage>.</citation>
</ref>
<ref id="bibr98-0148607112456041">
<label>98.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ishikawa</surname><given-names>Y</given-names></name>
<name><surname>Yoshida</surname><given-names>H</given-names></name>
<name><surname>Mamada</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>Prospective randomized controlled study of short-term perioperative oral nutrition with branched chain amino acids in patients undergoing liver surgery</article-title>. <source>Hepatogastroenterology</source>. <year>2010</year>;<volume>57</volume>(<issue>99-100</issue>):<fpage>583</fpage>-<lpage>590</lpage>.</citation>
</ref>
<ref id="bibr99-0148607112456041">
<label>99.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yoshida</surname><given-names>R</given-names></name>
<name><surname>Yagi</surname><given-names>T</given-names></name>
<name><surname>Sadamori</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>Branched-chain amino acid-enriched nutrients improve nutritional and metabolic abnormalities in the early post-transplant period after living donor liver transplantation</article-title> [published online September 23, 2011]. <source>J Hepatobiliary Pancreat Sci</source>.</citation>
</ref>
<ref id="bibr100-0148607112456041">
<label>100.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kawamura</surname><given-names>E</given-names></name>
<name><surname>Habu</surname><given-names>D</given-names></name>
<name><surname>Morikawa</surname><given-names>H</given-names></name><etal/>
</person-group>. <article-title>A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for pre-liver transplant status</article-title>. <source>Liver Transpl</source>. <year>2009</year>;<volume>15</volume>(<issue>7</issue>):<fpage>790</fpage>-<lpage>797</lpage>.</citation>
</ref>
<ref id="bibr101-0148607112456041">
<label>101.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hoffmann</surname><given-names>K</given-names></name>
<name><surname>Buchler</surname><given-names>MW</given-names></name>
<name><surname>Schemmer</surname><given-names>P</given-names></name>
</person-group>. <article-title>Supplementation of amino acids to prevent reperfusion injury after liver surgery and transplantation: where do we stand today?</article-title> <source>Clin Nutr</source>. <year>2011</year>;<volume>30</volume>(<issue>2</issue>):<fpage>143</fpage>-<lpage>147</lpage>.</citation>
</ref>
<ref id="bibr102-0148607112456041">
<label>102.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ijichi</surname><given-names>C</given-names></name>
<name><surname>Matsumura</surname><given-names>T</given-names></name>
<name><surname>Tsuji</surname><given-names>T</given-names></name>
<name><surname>Eto</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2003</year>;<volume>303</volume>(<issue>1</issue>):<fpage>59</fpage>-<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr103-0148607112456041">
<label>103.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Matsumura</surname><given-names>T</given-names></name>
<name><surname>Morinaga</surname><given-names>Y</given-names></name>
<name><surname>Fujitani</surname><given-names>S</given-names></name>
<name><surname>Takehana</surname><given-names>K</given-names></name>
<name><surname>Nishitani</surname><given-names>S</given-names></name>
<name><surname>Sonaka</surname><given-names>I</given-names></name>
</person-group>. <article-title>Oral administration of branched-chain amino acids activates the mTOR signal in cirrhotic rat liver</article-title>. <source>Hepatol Res</source>. <year>2005</year>;<volume>33</volume>(<issue>1</issue>):<fpage>27</fpage>-<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr104-0148607112456041">
<label>104.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nishitani</surname><given-names>S</given-names></name>
<name><surname>Ijichi</surname><given-names>C</given-names></name>
<name><surname>Takehana</surname><given-names>K</given-names></name>
<name><surname>Fujitani</surname><given-names>S</given-names></name>
<name><surname>Sonaka</surname><given-names>I</given-names></name>
</person-group>. <article-title>Pharmacological activities of branched-chain amino acids: specificity of tissue and signal transduction</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2004</year>;<volume>313</volume>(<issue>2</issue>):<fpage>387</fpage>-<lpage>389</lpage>.</citation>
</ref>
<ref id="bibr105-0148607112456041">
<label>105.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nakamura</surname><given-names>I</given-names></name>
<name><surname>Ochiai</surname><given-names>K</given-names></name>
<name><surname>Imawari</surname><given-names>M</given-names></name>
</person-group>. <article-title>Phagocytic function of neutrophils of patients with decompensated liver cirrhosis is restored by oral supplementation of branched-chain amino acids</article-title>. <source>Hepatol Res</source>. <year>2004</year>;<volume>29</volume>(<issue>4</issue>):<fpage>207</fpage>-<lpage>211</lpage>.</citation>
</ref>
<ref id="bibr106-0148607112456041">
<label>106.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nakamura</surname><given-names>I</given-names></name>
<name><surname>Ochiai</surname><given-names>K</given-names></name>
<name><surname>Imai</surname><given-names>Y</given-names></name>
<name><surname>Moriyasu</surname><given-names>F</given-names></name>
<name><surname>Imawari</surname><given-names>M</given-names></name>
</person-group>. <article-title>Restoration of innate host defense responses by oral supplementation of branched-chain amino acids in decompensated cirrhotic patients</article-title>. <source>Hepatol Res</source>. <year>2007</year>;<volume>37</volume>(<issue>12</issue>):<fpage>1062</fpage>-<lpage>1067</lpage>.</citation>
</ref>
<ref id="bibr107-0148607112456041">
<label>107.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kakazu</surname><given-names>E</given-names></name>
<name><surname>Kanno</surname><given-names>N</given-names></name>
<name><surname>Ueno</surname><given-names>Y</given-names></name>
<name><surname>Shimosegawa</surname><given-names>T</given-names></name>
</person-group>. <article-title>Extracellular branched-chain amino acids, especially valine, regulate maturation and function of monocyte-derived dendritic cells</article-title>. <source>J Immunol</source>. <year>2007</year>;<volume>179</volume>(<issue>10</issue>):<fpage>7137</fpage>-<lpage>7146</lpage>.</citation>
</ref>
<ref id="bibr108-0148607112456041">
<label>108.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kakazu</surname><given-names>E</given-names></name>
<name><surname>Ueno</surname><given-names>Y</given-names></name>
<name><surname>Kondo</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis</article-title>. <source>Hepatology</source>. <year>2009</year>;<volume>50</volume>(<issue>6</issue>):<fpage>1936</fpage>-<lpage>1945</lpage>.</citation>
</ref>
<ref id="bibr109-0148607112456041">
<label>109.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tsukishiro</surname><given-names>T</given-names></name>
<name><surname>Shimizu</surname><given-names>Y</given-names></name>
<name><surname>Higuchi</surname><given-names>K</given-names></name>
<name><surname>Watanabe</surname><given-names>A</given-names></name>
</person-group>. <article-title>Effect of branched-chain amino acids on the composition and cytolytic activity of liver-associated lymphocytes in rats</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2000</year>;<volume>15</volume>(<issue>8</issue>):<fpage>849</fpage>-<lpage>859</lpage>.</citation>
</ref>
<ref id="bibr110-0148607112456041">
<label>110.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gurusamy</surname><given-names>KS</given-names></name>
<name><surname>Kumar</surname><given-names>Y</given-names></name>
<name><surname>Davidson</surname><given-names>BR</given-names></name>
</person-group>. <article-title>Methods of preventing bacterial sepsis and wound complications for liver transplantation</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2008</year>;(<issue>4</issue>):CD006660.</citation>
</ref>
<ref id="bibr111-0148607112456041">
<label>111.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sugawara</surname><given-names>G</given-names></name>
<name><surname>Nagino</surname><given-names>M</given-names></name>
<name><surname>Nishio</surname><given-names>H</given-names></name><etal/>
</person-group>. <article-title>Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial</article-title>. <source>Ann Surg</source>. <year>2006</year>;<volume>244</volume>(<issue>5</issue>):<fpage>706</fpage>-<lpage>714</lpage>.</citation>
</ref>
<ref id="bibr112-0148607112456041">
<label>112.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Okabayashi</surname><given-names>T</given-names></name>
<name><surname>Nishimori</surname><given-names>I</given-names></name>
<name><surname>Sugimoto</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>Effects of branched-chain amino acids: enriched nutrient support for patients undergoing liver resection for hepatocellular carcinoma</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2008</year>;<volume>23</volume>(<issue>12</issue>):<fpage>1869</fpage>-<lpage>1873</lpage>.</citation>
</ref>
<ref id="bibr113-0148607112456041">
<label>113.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hasse</surname><given-names>JM</given-names></name>
<name><surname>Blue</surname><given-names>LS</given-names></name>
<name><surname>Liepa</surname><given-names>GU</given-names></name><etal/>
</person-group>. <article-title>Early enteral nutrition support in patients undergoing liver transplantation</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>1995</year>;<volume>19</volume>(<issue>6</issue>):<fpage>437</fpage>-<lpage>443</lpage>.</citation>
</ref>
<ref id="bibr114-0148607112456041">
<label>114.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rayes</surname><given-names>N</given-names></name>
<name><surname>Seehofer</surname><given-names>D</given-names></name>
<name><surname>Hansen</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients</article-title>. <source>Transplantation</source>. <year>2002</year>;<volume>74</volume>(<issue>1</issue>):<fpage>123</fpage>-<lpage>127</lpage>.</citation>
</ref>
<ref id="bibr115-0148607112456041">
<label>115.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rayes</surname><given-names>N</given-names></name>
<name><surname>Seehofer</surname><given-names>D</given-names></name>
<name><surname>Theruvath</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation—a randomized, double-blind trial</article-title>. <source>Am J Transplant</source>. <year>2005</year>;<volume>5</volume>(<issue>1</issue>):<fpage>125</fpage>-<lpage>130</lpage>.</citation>
</ref>
<ref id="bibr116-0148607112456041">
<label>116.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nickkholgh</surname><given-names>A</given-names></name>
<name><surname>Schneider</surname><given-names>H</given-names></name>
<name><surname>Encke</surname><given-names>J</given-names></name>
<name><surname>Buchler</surname><given-names>MW</given-names></name>
<name><surname>Schmidt</surname><given-names>J</given-names></name>
<name><surname>Schemmer</surname><given-names>P</given-names></name>
</person-group>. <article-title>PROUD: effects of preoperative long-term immunonutrition in patients listed for liver transplantation</article-title>. <source>Trials</source>. <year>2007</year>;<volume>8</volume>:<fpage>20</fpage>.</citation>
</ref>
<ref id="bibr117-0148607112456041">
<label>117.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Plank</surname><given-names>LD</given-names></name>
<name><surname>McCall</surname><given-names>JL</given-names></name>
<name><surname>Gane</surname><given-names>EJ</given-names></name><etal/>
</person-group>. <article-title>Pre- and postoperative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy</article-title>. <source>Clin Nutr</source>. <year>2005</year>;<volume>24</volume>(<issue>2</issue>):<fpage>288</fpage>-<lpage>296</lpage>.</citation>
</ref>
<ref id="bibr118-0148607112456041">
<label>118.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaido</surname><given-names>T</given-names></name>
<name><surname>Mori</surname><given-names>A</given-names></name>
<name><surname>Ogura</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>Impact of enteral nutrition using a new immuno-modulating diet after liver transplantation</article-title>. <source>Hepatogastroenterology</source>. <year>2010</year>;<volume>57</volume>(<issue>104</issue>):<fpage>1522</fpage>-<lpage>1525</lpage>.</citation>
</ref>
<ref id="bibr119-0148607112456041">
<label>119.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McClave</surname><given-names>SA</given-names></name>
<name><surname>Martindale</surname><given-names>RG</given-names></name>
<name><surname>Vanek</surname><given-names>VW</given-names></name><etal/>
</person-group>. <article-title>Guidelines for the provision and assessment of nutrition support therapy in the adult critically ilI patient</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2009</year>;<volume>33</volume>:<fpage>277</fpage>-<lpage>316</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>